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INTRODUCTION
The goal of this Comment is to discuss and describe for the
non-scientist attorney: (1) the technologies involved in the three
major methods of DNA testing; (2) potential uses for the polymer-
ase chain reaction (PCR), and issues surrounding its use in the fo-
rensic setting, including the cases to date; and (3) proposed
regulations and legislative action. Also, this comment refutes some
of the criticisms levelled against DNA testing in general and at-
tempts to correct some of the errors in previously published legal
papers regarding DNA technology and cases. Prosecutors, com-
mercial laboratories, and the media are not the only ones who are
pushing DNA profiling evidence into court. It is hoped that the
"stunned defense bar"' will realize the tremendous exculpatory po-
tential of DNA analysis.
While the technique utilizing restriction fragment length
polymorphisms (RFLP) has been accepted by many more appellate
level and higher courts,2 PCR has also been accepted by some ap-
1. Janet C. Hoeffel, Note, The Dark Side of DNA Profiling. Unreliable Scientific Evi-
dence Meets the Criminal Defendant, 42 STAN. L. REV. 465 (1990); Rorie Sherman, DNA
Unraveling, 15 NAT'L L.J. 1 (1993).
2. United States v. Jakobetz, 955 F.2d 786 (2d Cir. 1992); People v. Axell, 81 Cal.
Rptr. 2d 411 (Cal. Ct. App. 1991); State v. Pennington, 393 S.E.2d 847 (N.C. 1990); Kelly v.
State, 792 S.W.2d 579 (Tex. Ct. App. 1990); Glover v. State, 787 S.W.2d 544 (Tex. Ct. App.
1990); State v. Woodall, 385 S.E.2d 253 (W. Va. 1989); Caldwell v. State, 393 S.E.2d 436
(Ga. 1990); People v. Wesley, 533 N.Y.S.2d 643 (N.Y. Co.Ct. 1988); Martinez v. State, 549
So.2d 694 (Fla. Dist. Ct. App. 1989); State v. Pennell, 584 A.2d 513 (Del. Super. Ct. 1989)
[DNA test results admitted, but not probability evidence]; Cobey v. State, 559 A.2d 391 (Md.
Ct. Spec. App. 1989); Andrews v. State, 533 So.2d 841 (Fla. Dist. Ct. App. 1988).
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pellate courts3 and by the Virginia Supreme Court.4 However, as
recently demonstrated by the California First District Court of Ap-
peal,5 acceptance of RFLP is not uniform. Given the overwhelming
acceptance and adoption of PCR in the scientific community, it is
likely that such acceptance by the judicial system will come with
time.
6
Probably because of the quantity of attention given RFLP,
commonly referred to as "DNA Fingerprinting," it is a little known
or appreciated fact that PCR was successfully used to the benefit of
the defense in the very first criminal case involving DNA analysis in
the country.7 However, PCR is useful for both the prosecution and
defense, as was shown in a recent San Mateo County, California
case. This case dramatically illustrated the usefulness of PCR in
both exonerating and implicating suspects of such crimes as sexual
assault.
BASIC GENETICS AND DNA REPLICATION
In recognition of the fact that many attorneys do not have easy
access to genetics texts 9 recent enough to describe PCR, and the
3. Fuller v. Texas, 827 S.W.2d 919 (Tex. Crim. App. 1992); Trimboli v. Texas, 817
S.W.2d 785 (Tex. Ct. App. 1991).
4. Spencer v. Commonwealth, 393 S.E.2d 609 (Va. 1990); Spencer v. Commonwealth,
385 S.E.2d 850 (Va. 1989); Spencer v. Commonwealth, 384 S.E.2d 775 (Va. 1989); Spencer v.
Commonwealth, 384 S.E.2d 785 (Va. 1989).
In another case, the Massachusetts Supreme Court agreed with an indigent defendant
that PCR might help exonerate him, but refused to require the state to fund post-conviction
investigations that might reveal exculpatory evidence. Commonwealth v. Davis, 574 N.E.2d
1007 (Mass. 1991).
5. People v. Barney, 10 Cal. Rptr.2d 731 (Cal. Ct. App. 1992).
6. The wide and enthusiastic support and acceptance of PCR in the scientific commu-
nity is illustrated by the inclusion of over 12,000 PCR references in the Medline database
accessed through LEXIS. A LEXIS (MEDIS, MEDLNE Library, 86-91 File) search
("polymerase w/l chain w/1 reaction") conducted on 14 Jan. 1993 retrieved 12,016 refer-
ences. A narrower, modified search ("and forens!") retrieved 94 references.
7. Pennsylvania v. Pestinakis, cited in DNA Typing Draws First Blood in Pennsylvania,
SCI. SLEUTHING NEWSL., Summer 1987, at 1, 1.
8. People v. Quintanilla, No. C-23691 (San Mateo Super. Ct., Aug. 16, 1991). In this
case, the DNA typing requested by the initial suspect excluded him. Based on this and other
evidence, the prosecution dismissed the charges against the suspect. Approximately one year
later, a second suspect, already under investigation in several rape cases, was implicated.
This suspect was included through PCR typing. Although various samples had been submit-
ted to Cellmark Diagnostics (Germantown, MD) for RFLP analysis, Cellmark was unable to
obtain banding patterns. Nonetheless, PCR results implicated him, he matched the original
victim's physical description, his wife possessed jewelry stolen from the victim, and his finger-
prints matched those lifted from her car. Following a Kelly-Frye hearing, the PCR evidence
was admitted in his trial, and he was convicted. Id.
9. For exhaustive coverage of genetics, the reader is referred to such texts as BENJA-
MIN LEWIN, GENES (2d ed. 1985); BRUCE ALBERTS ET AL., MOLECULAR BIOLOGY OF THE
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observation that accurate and sufficiently simple (yet detailed
enough to be useful) descriptions of DNA technology are few and
far between in the legal literature, a relatively large portion of this
comment is devoted to the science involved in DNA analysis.
Deoxyribonucleic acid (DNA) is the "genetic blueprint" or
"code" which makes each living organism, with the exception of
identical twins, unique from all others. DNA is contained within
every nucleated cell in the human body.10 With the exception of the
reproductive cells, human DNA is arranged in 23 pairs of distinct
and separate chromosomes." Each chromosome is composed of
many "genes"' 12 and the entire DNA complement is called the
"genome."' Thus, the human genome is composed of 46 total
chromosomes which are paired such that homologous chromo-
somes are bound together within the nucleus.
Chromosomes are divided into two general groups-the auto-
somes and sex (X and Y) chromosomes. Autosomes are all chro-
mosomes other than the sex chromosomes. Somatic human cells
(body cells that are non-reproductive) have 22 pairs of autosomes
and 1 pair of sex chromosomes. The total number of paired chro-
mosomes in somatic cells is called "diploid" (2n). Reproductive
cells (egg and sperm) are called "gametes" or "germ cells." Ga-
metes contain the "haploid" chromosome number (n). This means
CELL (1983); MAXINE SINGER & PAUL BERG, GENES AND GENOMES (1991), and virtually
any recent biology or molecular biology textbook.
10. The major portion of DNA in each cell is located within a "nucleus." Thus, cells
without nuclei do not contain DNA. While most cells are nucleated, such cells as the mature
red blood cells of mammals do not have nuclei and thus do not contain DNA. See Luis C.
JUNQUEIRA & JOSE CARNEIRO, BASIc HISTOLOGY 261 (4th ed. 1983).
Animals and plants also contain a minor amount of extrachromosomal DNA. This
DNA is contained within organelles responsible for energy production. Thus, in animal cells
this DNA is located within mitochondria; in plants, it is located within chloroplasts.
II. Humans have 22 matched pairs of autosomes and one pair of sex chromosomes.
LORNE T. KIRBY, DNA FINGERPRINTING 8 (1990).
12. Although the term "gene" was coined by Johanssen in the early 1900's, Gregor
Mendel advanced the concept of the "gene" as early as 1865. Id. at 7.
13. The human genome is composed of approximately 3 billion base pairs. Chromo-
somes range in size from about 80 to 300 million base pairs. It has been estimated that only a
minor fraction of DNA (perhaps less than 10%) represents coding DNA and regulatory
sequences. The remainder consists of repetitive and other sequences, the function and impor-
tance of which are not presently understood. Eric D. Green & Robert H. Waterston, The
Human Genome Project, Prospects and Implications for Clinical Medicine, 266 JAMA 1966,
1967 (1991).
Of the estimated 50,000 to 100,000 genes present in the human genome, approximately
5000 have been catalogued, 1900 have been assigned to particular chromosomes and 600 have
been isolated (in cloned form). Less than 0.1% of the DNA sequences in the human genome
have been determined. Id.
2003] BIOTECHNOLOGY / LIFE SCIENCES LAW 99
1993] POL YMERSE CHAIN RE4CTION 291
that they contain one copy of each autosome and one sex
chromosome.
Basically, one chromosome in each pair is inherited from the
individual's mother, and the other chromosome is inherited from
the father. Thus, during normal embryonic development, a particu-
lar gene from the father will be paired with the homologous gene
from the mother."t Each homologous chromosome pair contains
genes situated in pairs at certain places ("loci"). Paired genes
which code for certain characteristics are called "alleles."',
As organisms must be able to replenish dead cells as well as
produce gametes, DNA replication is an important facet of cell
growth and development. Each time somatic cells divide,' 6 DNA
replication must occur in order to ensure that each of the two
daughter cells will contain a diploid chromosomal number. 7 In the
first step of this complicated process, the rungs of the "ladder" are
separated between the paired bases to produce two "complemen-
tary" strands of DNA.'" Each strand becomes a "template" to
14. This is made possible by the process known as "meiosis," which occurs during the
development of eggs and sperm (gametes). LEWIN, supra note 9, at 688. In the process of
meiosis, after chromosomal replication occurs, the nucleus and cell divide twice to produce
four cells, each with one-half the original chromosome number. Thus, each gamete will con-
tain only one of the two homologues of the parent chromosomes (it is "haploid"). Somatic
cells contain two copies of each chromosome and are called "diploid." Id. at 27-33.
15. Alleles are alternate forms of the genes that determine the expression of some par-
ticular characteristic. KIRBY, supra note 11, at 7-8.
While a person may inherit the allele for blue eyes from one parent and the allele for
brown eyes from the other, only one eye color is normally expressed. In this example, the
brown eye gene is "dominant" and the blue eye gene is "recessive;" this brown-eyed person
would be "heterozygous" for the eye color gene. If the person had inherited brown eye genes
from both parents, he would be "homozygous" for the gene which codes for eye color. Id. at
8.
16. The process whereby a somatic cell divides after chromosomal replication is called
"mitosis." LEWIN, supra note 9, at 688.
17. For example, when skin is injured, new skin cells must be produced in order to
replace the dead ones. The skin cells surrounding the damaged area are stimulated to begin
dividing. The DNA of these cells is replicated and the cells undergo "mitosis," or cell divi-
sion. This ensures that normal skin cells containing the proper diploid number of chromo-
somes will replace those killed as a result of the injury.
18. DNA is commonly described as a "twisted helix," "twisted ladder," or "spiral stair-
case." The ladder rungs (or steps in the staircase) are composed of pairs of "nucleotide"
bases. Within DNA, there are four bases-adenine (A), thymine (T), cytosine (C) and gua-
nine (G). Normally, each base is paired with another through hydrogen bonds, with adenine
paired with thymine and cytosine paired with guanine. The ladder's handrails are composed
of sugar (deoxyribose) and phosphate molecules. Strictly speaking, a nucleotide is a base
connected to a sugar and a phosphate. The paired bases are often referred to as "base pairs."
It is the particular base sequence which determines the characteristics of the individual
animal.
The other nucleic acid, ribonucleic acid or "RNA," is composed of the same nucleotides,
with the exception that thymine is replaced by uracil (U) (which like thymine, pairs with
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which new nucleotides are added. To accomplish this, an enzyme
called "DNA polymerase" travels along each of these separated
"template" strands, binding complementary bases in their appropri-
ate places thereby building new ladders from each of the two
strands and producing two identical DNA molecules from one orig-
inal parent DNA. This process allows each daughter cell to contain
one DNA strand from the parent cell and maintains the genetic
integrity of the organism.
Although DNA polymerase is not entirely mistake-proof, it is
quite reliable and will faithfully reproduce the parent DNA mole-
cule. As DNA replication is a very important function in cell divi-
sion, DNA polymerases are not limited to complex animals."t
While there are many other enzymes involved in DNA replica-
tion,2° DNA polymerase is the enzyme of primary interest in the
polymerase chain reaction.
FORENSIC DNA ANALYSIS
The genes of greatest interest in genetic analysis are those for
which there are many variations and are thus termed
"polymorphic."'" Usually, for a locus to be considered
polymorphic, the most common allele must occur at a frequency of
less than 99% and according to the Hardy-Weinberg law, 22 at least
2% of the population must be heterozygous at that locus. 23 At the
molecular level, polymorphism may result from a single nucleotide
base change, or from a change in the number of tandem repeats in a
adenine). RNA is copied from the DNA and is involved in protein production. Some viruses
(e.g., the retroviruses, such as the human immunodeficiency viruses, and feline leukemia vi-
rus) have RNA as their genetic material instead of DNA.
19. Lower organisms such as bacteria, fungi and parasites have their own DNA
polymerases which carry out the same replication functions. As discussed below, DNA
polymerases and other enzymes from bacteria and other organisms are useful tools in molecu-
lar biology and genetic engineering.
20. For descriptions of the structures and functions of the various enzymes involved in
eukaryotic (e.g., human) and prokaryotic (e.g., bacteria) DNA replication, see the appropri-
ate chapters in ARTHUR KORNBERG, DNA REPLICATION (1980).
21. "Polymorphism" refers to different forms of the same basic structure. There are
many examples of polymorphism in human genetics, such as ABO blood types and eye color.
22. According to the Hardy-Weinberg law, in a large randomly mating population,
where no disturbances by outside influences such as mutation, migration, or selection exist,
the relative proportions of the different genotypes remain constant between generations.
KIRBY, supra note 11, at 168. See also Victor Weedn, DNA Profiling, I EXPERT EVIDENCE
REP. 61, 66 (1989), for a simple explanation of the Hardy-Weinberg principles.
The "genotype" is the genetic make-up of an organism. The "phenotype" is the appear-
ance or other characteristic of the organism which results from the interaction of its genetic
constitution with the environment. LEWIN, supra note 9, at 25, 689.
23. KIRBY, supra note 11, at 25.
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repetitive DNA sequence. The changes may be neutral, with no
detectable phenotypic effect, or they may result in the production of
different forms of the same protein or enzyme ("isozymes")24 or
they may be lethal.
There are three basic DNA analysis methods commonly used
to determine identity and relatedness between individuals: (1) direct
gene sequencing or "mapping," (2) RFLP, and (3) PCR. Prior to
testing by any of these methods, electrophoresis or spectrophotome-
try is often used to determine the amount and size characteristics of
the DNA present in the sample, if any.
Direct Sequencing
The goal of direct sequencing is to determine the exact nucleo-
tide sequence present in the DNA molecule of interest. 25 Because
DNA is ultimately responsible for the uniqueness of each individ-
ual, direct DNA sequencing is the only method which can deter-
mine identity with 100% accuracy.26
Understandably, mapping the large numbers of genes present
on each individual chromosome by direct sequencing requires Her-
culean efforts.27 Nonetheless, due to advances in equipment and
24. Id.
25. ALBERTS ET AL., supra note 9, at 185.
26. George Sensabaugh, Use of DNA Fingerprinting in Forensics, Paper presented at the
American Society for Microbiology, Northern California Branch and Northern California
Association of Public Health Microbiologists, 8th Annual Combined Fall Conference (Octo-
ber, 1991).
27. Sequencing the human genome is the goal of the "Human Genome Project," an
ambitious, international, 15-year (minimum) cooperative venture. Anthony V. Carrano,
Human Genome Project-A Global and Local Perspective, Paper presented at the American
Society for Northern California Branch and Northern California Association of Public
Health Microbiologists, 9th Annual Combined Fall Conference (Oct. 1992). PCR is largely
responsible for making a project of this magnitude feasible. As stated previously, in order to
analyze each genomic sequence, many copies of DNA are necessary. Thus, the researchers
must make thousands, if not millions, of copies of each gene. This would take much longer if
traditional methods of molecular cloning such as those described in R.W. OLD & S.B. PRIM-
ROSE, PRINCIPLES OF GENE MANIPULATION (4th ed. 1989) and J. SAMBROOK ET AL., MO-
LECULAR CLONING (2d ed. 1989) were necessary.
The implications of sequencing the human genome are staggering. The recent discover-
ies of the genes associated with muscular dystrophy, manic depression, cystic fibrosis, and
Alzheimer's disease are merely illustrative aspects of the tremendous potential presented by
this project. Hereditary defects may also be diagnosed more efficiently and earlier in
pregnancies. Eventually, such defects may be eliminated through sophisticated genetic tech-
niques. See Green & Waterston, supra note 13.
Concerns have arisen in association with the Human Genome Project, including privacy
issues related to the database which will be generated. See Deborah Jackson, Hacking the
Genome, Sc. AM., Apr. 1992, 128, 128, for a description of the problems involved in estab-
lishing the database. Other issues include patenting of the DNA involved in this project.
While some scientists within the National Institutes of Health desire to patent DNA of un-
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knowledge, the combination of either direct sequencing or RFLP
and PCR will probably become the third generation of DNA
testing.2
8
Restriction Fragment Length Polymorphism (RFLP)
A. Introduction
RFLP is the DNA testing technique commonly referred to
within the legal profession as "DNA fingerprinting," due to the
barcode-like results observed in the ultimate product of the analy-
sis.29 RFLP, the first generation in DNA analysis for casework,
was developed by Alec Jeffreys and his colleagues in Britain.30 It
has been used extensively in the United States, the United King-
dom,3 Canada32 and China.33 RFLP was used in the first sensa-
known coding specificities, many others are opposed to patenting these gene sequences. In
fact, this controversy over patenting contributed to the resignation of James Watson as the
head of the Human Genome Project. See Leslie Roberts, Two Strikes Against CDNA Patents,
257 ScL 1620 (1992).
28. See Carolyn S. Harrington et al., HLA DQca Typing of Forensic Specimens by Ampli-
fication Restriction Fragment Length Polymorphism (RFLP) Analysis, 51 FORENSIC SCL
INT'L 147 (1991); Kentaro Kasai et al., Amplification of a Variable Number of Tandem Re-
peats (VNTR) Locus (pMCTII8) by the Polymerase Chain Reaction (PCR) and Its Applica-
tion to Forensic Science, 35 J. FORENSIC SCI. 1196 (1990); Ulf B. Gyllensten & Henry A.
Erlich, Generation of Single-Stranded DNA by the Polymerase Chain Reaction and its Applica-
tion to Direct Sequencing of the HLA-DQA Locus, 85 PROC. NAT'L ACAD. SC,. 7652 (1988).
29. Because DNA typing is based on very different principles than traditional finger-
printing, it is somewhat unfortunate that the term "Fingerprinting" has been associated with
DNA testing. While this term has traditionally only referred to RFLP, some commentators
unfamiliar with the science and technology group all DNA testing methods, including PCR
applied to specific genetic loci within the term. Also, contrary to some accounts, "DNA
Fingerprinting" was not "discovered" by Jeffreys, it was invented by him. See Ricardo
Fontg, Comment, DNA Fingerprinting: A Guide to Admissibility and Use, 57 Mo. L. REV.
501, 502-503 (1992).
30. Jeffreys' work developed from fundamental research done by E.M. Southern on the
technique of "Southern blotting" DNA from electrophoresis gels onto membranes (E.M.
Southern, Detection of Specific Sequences Among DNA Fragments Separated by Gel Electra-
phoresis, 98 J. MOLECULAR BIOLOGY 503 (1975)) and the work of Wyman and White on a
polymorphic DNA locus which was characterized by a number of "variable number tandem
repeats," better known as VNTR's (A.R. Wyman & R. White, A Highly Polymorphic Locus
in Human DNA, 77 PROC. NATL. ACAD. SCI. USA 6754 (1980)).
Publication of Jeffrey's work heralded the present era of exploration into the study of
DNA in many disciplines. Alec J. Jeffreys et al., Hypervariable 'Minisatellite' Regions in
Human DNA, 314 NATURE 67 (1985).
31. See David J. Werrett et al., The Introduction of DNA Analysis Into Home Office
Forensic Science Laboratories in England and Wales, BANBURY REP. 32: DNA TECH. AND
FORENSIC Sci. 233 (1989).
32. See Barry D. Gaudette, Forensic DNA Analysis in the Royal Canadian Mounted
Police, BANBURY REP. 32: DNA TECH. AND FORENSIC SCi. 229 (1989).
33. See Xiao-Wei Zhang et al., Restriction Fragment Length Polymorphism Analysis of
Forensic Science Casework in the People's Republic of China, 36 J. FORENSIC SCI. 531 (1991).
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tionalized DNA criminal case, which catapulted DNA analysis into
the public and legal spotlight. 34
However, this case was not the first use of DNA profiling in
the forensic setting. Alec Jeffreys was also involved in a 1983 immi-
gration case involving the son of a Ghanian woman who was a legal
resident of the United Kingdom. When authorities refused to allow
the boy to immigrate to the U.K., Jeffreys was able to show that
there was only a one in 6 X 10- 6 probability that the boy was not
the woman's son. Conceding that as the world's population was
only about 4 billion, authorities eventually allowed the boy to immi-
grate." Thus, RFLP has found an important niche in paternity (or
maternity) testing, as it correlates well with traditional methods and
may be very informative in cases where traditional methods yield
inconclusive or insufficient results.
36
Because of the tedious, time-consuming, labor-intensive and
subjective procedures which require specific training in the tech-
niques of molecular biology, RFLP is perhaps best done in research
labs. Presently, there are relatively few forensic labs which use
RFLP (such as Lifecodes, Cellmark, GeneScreen, the Department
of Justice, and the FBI).
While someone sufficiently trained in the methodology may
consistently obtain meaningful results, it is an inherently complex
test system. This is probably one of the reasons why the large pri-
vate labs (e.g., Cellmark and Lifecodes) are primarily molecular bi-
ology laboratories. Their forensic work is simply an offshoot of
their primary efforts related to genetic testing.
Given the technical challenges37 involved in the development
34. This highly celebrated British case was the subject of Joseph Wambaugh's book,
THE BLOODING (1989). The case involved three quiet villages in Leicester, two murdered 15-
year old girls, a baker named Colin Pitchfork, a colleague named Ian Kelly who passed
himself off as Pitchfork in the massive DNA sample collection efforts which led to the sub-
mission of samples from 5,512 males between the ages of 13 and 30 residing in the villages,
and a geneticist named Alec Jeffreys. In this case, reports indicated that the odds against two
unrelated persons having the same banding pattern as the suspect and Pitchfork was about 30
billion to one. Anthony Schmitz, Murder on Black Pad, HIPPOCRATES, Jan-Feb. 1988, at 49.
35. For an account of this case, see Alec J. Jeffreys et al., Positive Identification of an
Immigration Test-Case Using Human DNA Fingerprints, 317 NATURE 818 (1985); William
G. Hill, DNA Fingerprint Analysis in Immigration Test-Cases, 322 NATURE 290 (1986); John
I. Thornton, DNA Profiling, CHEMICAL ENGINEERING NEWS, Nov. 20, 1989, at 18.
36. Lois A. Tonelli et al., Use of Deoxyribonucleic Acid (DNA) Fingerprints for Identity
Determination: Comparison with Traditional Paternity Testing Methods-Part 1, 35 J. FOREN-
SIC SCd. 1265 (1990); Karen R. Markowicz et al., Use ofDeoxyribonucleic Acid (DNA) Finger-
prints for Identity Determination: Comparison with Traditional Paternity Testing Methods-
Part H, 35 J. FORENSIC SCI. 1270 (1990).
37. These challenges include: (1) preliminary sequencing of the DNA of interest; (2)
production of oligonucleotide probes (strings of single-stranded nucleotide bases complemen-
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of useful RFLP systems, it is easy to understand why molecular
biologists have been involved in this type of research. While some
criminalists are molecular biologists, many must return to school to
learn the language and methods of molecular biology in order to
become proficient. Forensic scientists, such as criminalists who
conduct DNA analyses, must truly have a hybrid education-they
must apply their knowledge and understanding of the forensic sci-
ence world in the realm of molecular biology. They must have a
good working knowledge of the legal system, particularly in areas
related to the evidentiary system and testifying in court. Unlike the
molecular biologist working in the research setting, criminalists
must put their reputations on the line every time they testify as to
their laboratory results; their techniques and methods are continu-
ously under close scrutiny. Thus, while research molecular biolo-
gists play important and necessary roles in the development of
forensic DNA tests, the members of the forensic community are in
the best position to determine and designate the optimal routes to
take in the ongoing collaboration of forensics and molecular
biology.
B. Technology
Basically, RFLP involves (1) using restriction enzymes to chop
up the DNA of interest into segments of differing sizes and molecu-
lar weights;38 (2) running these DNA segments on an electrophore-
tary to the DNA of interest); (3) dealing with the vagaries of electrophoresis and "Southern"
blots; (4) subjective analysis of differences in band migration through the electrophoresis gel;
and (5) the infamous "band shift" frequently mentioned in RFLP court cases such as People
v. Castro, 545 N.Y.S.2d 985 (N.Y. Sup. Ct. 1989). See also Colin Norman, Maine Case Deals
Blow to DNA Fingerprinting 246 Sci. 1556, 1557-1558 (1989).
38. As indicated above, see supra note 13, most of the human genome is composed of
"non-coding" DNA (DNA that does not contain the code for a protein). Within these non-
coding regions, there are repetitive segments of varying lengths. These repetitive segments
are called VNTRs (variable number tandem repeats) because they are composed of sequences
of nucleotide bases which are repeated in tandem, any number of times. Thus, VNTRs are
polymorphic-different individuals will have a different number of repeated sequences at a
particular spot in the genome.
Restriction enzymes recognize specific base pair sequences and will cleave the DNA only
at these particular sites. Thus, if a specific recognition base sequence is present, a restriction
enzyme which recognizes that site will cleave the DNA molecule to produce fragments of a
certain length. If the site is absent, a fragment of different length will be produced.
Polymorphism often results from neutral changes (changes in which mutations create or
abolish recognition sites for restriction enzymes in noncoding DNA). KIRBY, supra note 11,
at 26. Obviously, if changes occur within controlling sequences or structural genes (e.g.,
those which code for proteins), there may be serious phenotypic consequences (such as cystic
fibrosis). Id.
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sis ge 3 9 to separate them into "bands" based on their size and
weight; (3) denaturing the DNA to make it single-stranded; (4)
"blotting" the DNA onto a membrane; (5) adding radioactively-
labelled DNA oligonucleotide probes complementary to a particu-
lar sequence of interest; (6) exposing the membrane to X-ray film to
produce an autoradiogram; (7) observing the banding patterns pro-
duced by the radioactive probes on the autoradiogram (or
"autorad"); and (8) comparing the banding patterns produced by
the different test samples.
Because many DNA samples are run in different lanes on the
electrophoresis gel at the same time,' the scientist is able to com-
pare the migration distances of the bands in each lane separated in
the gel during electrophoresis. If the banding patterns in two sam-
ples are identical, this indicates the samples may have originated
from the same source.
By using various restriction enzymes, the scientist can produce
different DNA segments with correspondingly different base se-
quences and lengths. Through sample comparisons, the use of mul-
tiple restriction enzymes, and statistical methods, the analyst
determines whether the "evidence" sample was from the suspect,
victim or someone else. "Direct sexing" of DNA may be used as an
internal control and/or for sex determination in cases where the sex
of the person is unknown.4 '
One major problem with RFLP that is commonly dealt with in
the forensic setting is the minute amount of sample which is often
the only evidence available. Current RFLP technology requires 1
to 10 g of DNA for a single analysis.
39. Electrophoresis is a technique commonly used to separate component parts of pro-
teins, nucleic acid fragments or other molecules. In RFLP, the restriction enzyme-treated
sample DNA is placed in a lane on an agarose gel (or other gel material). When an electric
current is applied to the gel, the DNA fragments move through the gel at rates dependent
upon such factors as their electrical charges, size and weight.
For a detailed description of the technical aspects involved in RLFP, see KIRBY, supra
note 11, at 91-131, 135-145.
40. In addition to the samples from each person involved and any evidence samples
available, a size-marker DNA cocktail is also run in one lane. This sample, containing DNA
fragments of known molecular weight and size, is used as a reference to determine the
number of base pairs which correspond to each band in the test sample patterns.
The "blotting" of DNA fragments from an agarose gel to a more solid support, such as a
nylon membrane or cellulose acetate filter paper, for subsequent detection is called "Southern
blotting," named for the researcher who originally developed the technique. See Southern,
supra note 30, at 29.
41. Lilya V. Verbovaya & Pavel L. Ivanov, "Sexing" Deoxyribonucleic Acid (DNA) on
DNA Fingerprint Gel: An Internal Control for DNA Fingerprint Evidence, 36 J. FORENSIC SCI.
991 (1991).
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Blood contains 5000 to 10,000 nucleated cells per microlitre; this
corresponds to 25 to 50 Rig of DNA/mL. Thus bloodstains
would have to contain at least 50 [LL of blood to be amenable to
analysis. The corresponding limit value for semen is about 10
ILL. To put this latter value in context, a vaginal swab holds
about 100 lL of fluid; thus semen collected on swabs cannot be
diluted more than about 1:10.42
This is also a problem when multiple test procedures are neces-
sary. The decision must then be made whether to use the entire
sample for RFLP anaylsis, or forego RFLP in favor of other ana-
lytic methods. Another consideration is that there may be an insuf-
ficient quantity of high molecular weight DNA available due to
sample degradation by bacterial action, sunlight or other DNA-de-
stroying forces. The relative stability of dried DNA has been stud-
ied in controlled experimental studies,43 as well as from teeth,'
mummy tissue and 140-year-old dried muscle.45 In some cases,
RFLP is possible.46 However, this is not always the case, and other
methods such as PCR are sometimes required.
In addition to requiring relatively large samples, RFLP has a
major drawback in that it commonly involves the use of radioactive
reagents, a distinct disadvantage for crime labs. Unlike most
42. George F. Sensabaugh, Forensic Biology-Is Recombinant DNA Technology in its
Future?, 31 J. FORENSIC Sci. 393, 395 (1986).
43. Peter Gill et al., Forensic Application of DNA Fingerprints, 318 NATURE 577 (1985);
Dwight E. Adams et al., Deoxyribonucleic Acid (DNA) Analysis by Restriction Fragment
Length Polymorphisms of Blood and Other Body Fluid Stains Subjected to Contamination and
Environmental Insults, 36 J. FORENSIC SCI. 1284 (1991); David J. Walsh et al., Isolation of
Deoxyribonucleic Acid (DNA) From Saliva and Forensic Science Samples Containing Saliva,
37 J. FORENSIC Sci. 387 (1992); Terry L. Laber et al., Evaluation of Four Deoxyribonucleic
Acid (DNA) Extraction Protocols for DNA Yield and Variation in Restriction Fragment
Length Polymorphism (RFLP) Sizes Under Varying Gel Conditions, 37 J. FORENSIC SCi. 404
(1992); C.T. Comey & Bruce Budowle, Validation Studies on the Analysis of the HLA-DQs
Locus Using the Polymerase Chain Reaction, 36 J. FORENSIC SCI. 1633 (1991)
44. Ted R. Schwartz et al., Characterization of Deoxyribonucleic Acid (DNA) Obtained
from Teeth Subjected to Various Environmental Conditions, 36 J. FORENSIC SCI. 979 (1991);
John S. Waye et al., Sensitive and Specific Quantitation of Human Genomic Deoxyribonucleic
Acid (DNA) in Forensic Science Specimens: Casework Examples, 36 J. FORENSIC SCI. 1198
(1991).
45. R. Higuchi et al., DNA Sequences From the Quagga, an Extinct Member of the
Horse Family, 312 NATURE 282 (1984).
46. J.E. Allard, Murder in South London: A Novel Use of DNA Profiling, 32 J. FOREN-
SIC SCI. Soc'Y 49 (1991); William D. Haglund et al., Identification of Decomposed Human
Remains by Deoxyribonucleic Acid (DNA) Profiling, 35 J. FORENSIC Sci. 724 (1990); Evan
Kanter et al., Analysis of Restriction Fragment Length Polymorphisms in Deoxyribonucleic
Acid (DNA) Recovered From Dried Bloodstains, 31 J. FORENSIC Scl. 403 (1986); Alan Giusti
et al., Application of Deoxyribonucleic Acid (DNA) Polymorphisms to the Analysis of DNA
Recovered From Sperm, 31 J. FORENSIC Sci. 409 (1986); S. Paibo, Molecular Cloning of
Ancient Egyptian Mummy DNA, 314 NATURE 644 (1985); Higuchi supra note 45.
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clinical laboratories, many forensic labs do not have the facilities
required for isotope work.4 7 Major concerns associated with the use
of radioactive reagents include their cost, relatively short half-lives
(while some of the radioactivity may remain for a long time, the
reagent will degrade to the point where it is no longer sensitive
enough for use in the test system), hazardous waste disposal consid-
erations, the need to monitor personnel and lab space for radiation
dose and contamination, and licensing regulations. If a spill occurs,
it is possible that at least a portion of the laboratory will become
unusable because no one will be allowed to enter the contaminated
area. Due to these factors, many laboratorians are unwilling to ac-
cept the risks and disadvantages of using radioactive test methods.
These concerns have helped stimulate the development of much
simpler and less dangerous test methods (e.g., PCR) which utilize
enzyme-based detection systems, rather than radioactive labels.
One strong advantage of RFLP is that it is possible to derive
phenomenonal probability statistics relating to the determination of
whether a particular person is responsible for the crime under inves-
tigation. The greater the probability that the RFLP patterns ob-
served in the evidence samples and the subject match, the greater
the likelihood that the person is the one responsible for the crime.4"
There are even methods which may be used to determine the iden-
tity of a suspect who claims that another family member was re-
sponsible for the crime.4" Thus, RFLP's "power of discrimination"
is potentially very high.
Because population genetics form the basis for these determi-
nations, there has been much research into the genetic makeup of
various human subpopulations5 0 The methods used to estimate the
probabilities are relatively complex. In the forensic setting, most
47. Sensabaugh, supra, note 42, at 396.
48. "In any case, using a single probe, . . . [t]he probability that another, unrelated
individual would share exactly the same pattern is 3 X 10-". Add the products of a second
probe, and the probability shrinks further, to 5 X 10""." Roger Lewin, DNA Fingerprints in
Health and Disease, 233 Sci. 521, 522 (1986).
In a recent appellate case, the frequency of the defendant's genotype in the Caucasian
population was determined to be one in 300 million. United States v. Jakobetz, 955 F.2d 786,
789 (2d Cir. 1992).
49. I.W. Evett, Evaluating DNA Profiles in a Case Where the Defence is "It was my
brother, " 32 J. FORENSIC ScI. Soc'Y 5 (1992).
50. M. Baird et al., Allele Frequency Distribution of Two Highly Polymorphic DNA Se-
quences in Three Ethnic Groups and Its Application to the Determination of Paternity, 39 AM.
J. HuM. GENETICS 489 (1986); Balazs et al., Human Population Genetic Studies of Five
Hypervariable DNA Loci, 44 AM. J. HUM. GENETICS 182 (1989). See also, Robert Gaensslen,
When Blood is Their Argument: Use and Interpretation of Genetic Marker Frequency Data in
Forensic Serology, 12 CRIME LABORATORY DIG. 75 (1985).
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discussion has centered around two statistical methods. For exam-
ple, the FBI uses a "fixed bin method" to establish this
probability." The National Research Council's (NRC) Committee
on DNA Technology in Forensic Science recommend the "ceiling
principle" as a method which is even more conservative than the
FBI's fixed bin method.5 2 As discussed below, population genetics
and the statistics used to produce impressive probabilities are a sub-
ject of concern to many commentators and expert witnesses.5 3
Perhaps, in their rush to gain court acceptance of RFLP, its
advocates have been overzealous in promoting its discriminatory ca-
pabilities. It is one thing to say that there is a 1 chance in a million
that this test has identified the person responsible for the crime. It
may be too much for many people to comprehend that there is a 1
chance in 1,000,000,000,000. Its extraordinary claims make it
somewhat suspicious, much like the promises made by the patent
medicine salesman from an earlier time in our history. The claims
simply seem too good to be true. Thus, association of such claims
with the test method may make it much easier for the judge or jury
to disregard the evidence as untrustworthy.
Although some of the distrust associated with RFLP has over-
flowed into the PCR arena, the concerns with PCR are much differ-
ent than those associated with RFLP. Also because its power of
discrimination is not as great as that of RFLP, such claims of unre-
liability based on skewed population genetics and statistics are not
as applicable to PCR.
The Polymerase Chain Reaction (PCR)
A. History
While at Cetus, biochemist and researcher Kary Mullis con-
ceived and began developing methods to use polymerase to produce
51. For a detailed explanation of this statistical method, see Bruce Budowle & Keith L.
Monson, A Statistical Approach For VNTR Analysis, 1989 PRoC. INT'L SyMP. FORENSIC
ASPECTS DNA ANALYSIS, 121 (1989). See also, The FBI's Response to Recommendations by
the Committee on DNA Technology in Forensic Science of the National Research Council,
National Academy of Science, 19 CRIME LABORATORY DIG. 57-59 (1992).
52. NATIONAL RESEARCH COUNCIL, DNA TECHNOLOGY IN FORENSIC SCIENCE 90-
93 (1992).
53. Bruce Budowle & John Stafford, Response to Expert Report by D.L. Hartd Submit-
ted in the Case of United States v. Yee, 18 CRIME LABORATORY DIG. 101 (1991); Bruce
Budowle & John Stafford, Response to "Population Genetic Problems in the Forensic Use of
DNA Profiles" by R.C Lewontin Submitted in the Case of United States v. Yee, 18 CRIME
LABORATORY DIG. 109 (1991); Eric S. Lander, Population Genetic Considerations in the Fo-
rensic Use of DNA Typing, BANBURY REP. 32: DNA TECH. AND FORENSIC SCI. 143 (1989).
See also Eric Lander, Expert's Report in People v. Castro (undated).
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multiple DNA copies.54 The elegant simplicity and tremendous
theoretical potential of this DNA multiplication scheme has revolu-
tionized molecular biology. Indeed, it rapidly became the method
of choice of molecular biologists and others who study DNA.
"While the field of forensic serology was being revolutionized by the
prospect of DNA analysis, the field of molecular biology was being
revolutionized by the invention of the polymerase chain reaction
(PCR), which ultimately has had an impact on every area of biolog-
ical science." '  Given its utility, it is perhaps not surprising that
PCR represents a significant intellectual property concern with im-
mense economic potential.
5 6
54. See K. Mullis & F. Faloona, Specific Synthesis of DNA In Vitro Via a Polymerase
Catalysed Chain Reaction, 155 METHODS ENZYMOLOGY 335 (1987); K. Mullis et al., Specific
Enzymatic Amplification of DNA in Vitro: The Polymerase Chain Reaction, 51 COLD SPRING
HARBOR SYMP ON QUANTITATIVE BIOLOGY 263 (1986); Randall K. Saiki et al., Enzymatic
Amplification of P-Globin Genomic Sequences and Restriction Site Analysis For Diagnosis of
Sickle Cell Anemia, 230 Sci. 1350 (1985); Randall K. Saiki et al., Analysis of Enzymatically
Amplified 0-Globin and HLA-DQa DNA With Allele-Specific Oligonucleotide Probes 324 NA-
TURE 163 (1986).
55. Rebecca Reynolds et al., Analysis of Genetic Markers in Forensic DNA Samples Us-
ing the Polymerase Chain Reaction, 63 ANALYTICAL CHEMISTRY 1,1 (1991).
56. Cetus successfully defended two very important PCR patents (U.S. Patent Nos.
4,683,195 and 4,683,202) against Du Pont in 1991. Du Pont De Nemours & Co. v. Cetus
Corp., 19 U.S.P.Q. 2d (BNA) 1174 (N.D. Cal. 1990); Du Pont De Nemours & Co. v. Cetus
Corp. No. 89-2860, 1990 U.S. Dist. LEXIS 18382 (N.D. Cal. Dec. I1, 1991).
Until Cetus sold its entire GeneAmp PCR technology business to Hoffman-La Roche for
an aggregate cash price of $300 million plus royalties on future Roche PCR sales, Cetus sold
PCR equipment through a joint venture with Perkin-Elmer. Cetus To Sell PCR Business to
Hoffman-La Roche for $300 Million Plus Royalties, Bus. WIRE, July 22, 1991, available in
LEXIS/Nexis Library Bus. Wire File. PCR sales through the joint venture amounted to $26
million for the fiscal year ending June, 1991 and were expected to grow 40-50% in 1992.
Sabin Russell, Cetus Wins Patent Case Over Du Pont: Crucial Victory For Biotech Firm, S.F.
CHRON., Feb. 28, 1991, at Cl.
Cetus and Chiron Corporation recently merged to form the second largest independent
biotechnology firm. The new company, worth about $600 million in cash assets, focuses on
diagnostics, vaccines, cancer therapeutics and ophthalmics. Chiron and Cetus to Form "Sec-
ond Largest" Biotech Firm, BIOTECHNOLOGY NEWSWATCH, August 5, 1991, at 1. Almost
simultaneously with the Chiron merger, Cetus sold the PCR rights to Roche. Emma Chy-
noweth, Cetus Sells Diagnostics to Roche, Merges With Chiron, CHEMICAL WK., July 31,
1991, at 12. Prior to the sale, Roche agreed to abide by the decision in a lawsuit brought
against Cetus by Eastman Kodak Company to seek injunctive relief in regard to technology
co-developed during the terms of an agreement between Cetus and Kodak. Stockholders
Make it Official: Chiron, Cetus to Merge, Roche Acquires PCR, BIOTECHNOLOGY NEW-
SWATCH, December 16, 1991, at 1; Eastman Kodak Co. v. Cetus Corp., 1991 Del. Ch.
LEXIS 151 (Del. Ch. Oct. 4, 1991); See also, Eastman Kodak Co. v. Cetus Corp., 1991 Del.
Ch. LEXIS 197 (Del. Ch. Dec. 11, 1991).
Hoffman LaRoche is aggressively enforcing its rights to the large Taq market (in Eu-
rope, it was valued at $26 million in 1991), as demonstrated by the recent suit filed against
Promega. See Peter Aldhous, Roche Gets Tough on Illicit Sales of PCR Reagent, 258 ScI.
1572 (1992).
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While much attention has been focused on the somewhat con-
troversial Human Genome Project, PCR is also becoming increas-
ingly important in many other areas. Development of PCR
methods led to the subsequent development of the DQa test used in
the forensic setting," human immunodeficiency virus (HIV) detec-
tion and diagnostic techniques,5" methods for the identification and
detection of other microorganisms in various settings, including the
aquatic environment, food, dairy, soil and clinical samples,59 neona-
tal screening' (e.g., detection of genes associated with cystic
fibrosis,6 and sickle cell anemia62 ), identification methods for chro-
57. Henry A. Erlich et al., The Use of the Polymerase Chain Reaction for Genetic Typ-
ing in Forensic Samples, 1989 PROC. INT'L SYMP. FORENSIC ASPECTS DNA ANALYSIS 93;
George F. Sensabaugh, Forensic Application of the Polymerase Chain Reaction, 31 J. FOREN-
sic Sci. Soc'Y 201 (1991); Rebecca Reynolds et al., supra note 55; Atsushi Akane et al., Sex
Identification of Forensic Specimens By Polymerase Chain Reaction (PCR): Two Alternative
Methods, 49 FORENSIC SCI. INT'L 81 (1991); Cetus Corporation, Forensic Analysis By the
Polymerase Chain Reaction (PCR), CETUS BACKGROUNDER, Feb. 1990; James J. Harring-
ton, An Evaluation of the Forensic Application of the Polymerase Chain Reaction Technique
for Use in New Jersey: Legal and Scientific Considerations, (unpublished manuscript).
58. Chin-Yih Ou, DNA Amplification For Direct Detection of HIV-i in DNA of Periph-
eral Blood Mononuclear Cells, 239 Sci. 295 (1988); M.F. Rogers et al., Use of the Polymerase
Chain Reaction For Early Detection of the Proviral Sequences of Human Immunodeficiency
Virus in Infants Born to Seropositive Mothers, 320 NEW ENG. J. MED. 1649 (1989); M. Ray-
field et al., Mixed Human Immunodeficiency Virus (HIV) Infection in an Individual. Demon-
stration of Both HIV Type I and Type 2 Proviral Sequences By Using Polymerase Chain
Reaction, 158 J. INFECTiOUS DISEASES 1170 (1988).
59. E.J. Thomas et al., Sensitive and Specific Detection of Listeria Monocytogenes in
Milk and Ground Beef with the Polymerase Chain Reaction, 57 APPL. ENVIRON. MICROBIOL.
2576 (1991); Henry A. Erlich et al., Recent Advances in the Polymerase Chain Reaction, 252
Sci. 1643, 1649 (1991); David H. Persing, Polymerase Chain Reaction. Trenches to Benches,
29 J. CLINICAL MICROBIOL. 1281 (1991); Richard A. Gibbs, DNA Amplification by the
Polymerase Chain Reaction, 62 ANALYTICAL CHEM. 1202 (1990); Deborah Y. Kwoh & T.
Jesse Kwoh, Target Amplification Systems in Nucleic Acid-Based Diagnostic Approaches, AM.
BIOSCIENCES LABORATORY 14 (Oct. 1990); Polymerase Chain Reaction Project Exploring Po-
tential Clinical Applications, AIDS RES. EXCHANGE, July/Aug. 1989, at 1; Ichiro Saito et
al., Detection of Epstein-Barr Virus DNA by Polymerase Chain Reaction in Blood and Tissue
Biopsies From Patients with Sogren's Syndrome, 169 J. EXPERIMENTAL MED. 2191 (1989);
Shuichi Kaneko et al., Detection of Serum Hepatitis B Virus DNA in Patients with Chronic
Hepatitis Using the Polymerase Chain Reaction Assay, 86 PROC. NAT'L ACAD. SCI. 312
(1989).
60. Edward R.B. McCabe et al., DNA Microextraction From Dried Blood Spots on Filter
Paper Blotters: Potential Applications to Newborn Screening, 75 HUM. GENETICS 213 (1987);
Edward M. Rubin et al., Newborn Screening by DNA Analysis of Dried Blood Spots, 82 HUM.
GENETICS 134 (1989).
61. C. Williams et al., Same Day, First-Trimester Antenatal Diagnosis For Cystic Fibro-
sis By Gene Amplification, 2 LANCET 102 (1988); A. Handyside et al., Birth of a normal girl
after in vitro fertilization and preimplantation diagnostic testing for cystic fibrosis, 327 NEW
ENG. J. MED. 905.
62. R.K. Saiki et al., Enzymatic Amplification of f-globin Genomic Sequences and Re-
striction Site Analysis For Diagnosis of Sickle CellAnemia, 230 Sci. 1350 (1985); S.H. Embury
et al., Rapid Prenatal Diagnosis of Sickle Cell Anaemia By a New Method of DNA Analysis,
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mosomal abnormalities and specific mutations,63 gene replacement
therapy" and the development of other tests too numerous to men-
tion.65 PCR can even be used to determine ABO genotypes and
sex.66 The ability of PCR to amplify DNA from both a single
human sperm and a diploid cell represents a major breakthrough in
human pedigree analysis.67 PCR is also useful in cases where the
person is dead, but some of their tissues have been preserved in par-
affin.6" Use of these preserved samples precludes the necessity of
exhumation and allows DNA analysis on those who have been cre-
mated. PCR methods such as the AmpliTypeq DQa kit may also
be used in cases where bones are available for analysis.69 PCR has
also been used to study the epidemiology of Lyme disease, a re-
cently recognized, yet ancient disease.7 °
316 NEW ENG. J. MED. 656 (1987). PCR can also be used to diagnose many other genetic
diseases, such as Huntington's disease (I. McIntosh et al., Prenatal Exclusion Testing for
Huntington Disease Using the Polymerase Chain Reaction, 32 AM. J. MED. GENETICS 274
(1989)), and phenylketonuria (Cynthia Bottema et al., Direct Carrier Testing for
Phenylketonuria by PCR Amplification of Specific Alleles, AMPLIFICATIONS, Mar. 1990, at
27).
63. PCR made the identification of chronic myeloid leukemia as the first cancer in
which a specific genetic abnormality was identified. Ernest S. Kawasaki et al., Diagnosis of
Chronic Myeloid and Acute Lymphocytic Leukemias by Detection of Leukemia-Specific
mRNA Sequences Amplified In Vitro, 85 PROC. NAT'L ACAD. SCI. USA 5698 (1988).
64. Mark R. Hughes & C. Thomas Caskey, Medical Genetics, 265 JAMA 3132 (1991).
65. For an excellent review of the applications of PCR in medical diagnostics for ge-
netic diseases, see Barry 1. Eisenstein, The Polymerase Chain Reaction, New Method of Using
Molecular Genetics for Medical Diagnosis, 322 NEW ENG. J. MED. 178 (1990). See also,
Shirley Kwok & John Sninsky, Application of PCR to the Detection of Human Infectious
Diseases, in PCR TECHNOLOGY 235 (Henry A. Ehrlich ed., 1989).
For an excellent recent overview of PCR and its multitude of applications, see Henry A.
Erlich et al., supra note 57.
66. James Chun-I Lee & Jan-Gowth Chang, ABO Genotyping by Polymerase Chain Re-
action, 37 J. FORENSIC SCI. 1269 (1992); Rebecca Reynolds, Rapid Determination of Gender
Using the Polymerase Chain Reaction, Paper presented at the 77th Semi-Annual Seminar of
the California Association of Criminalists (May, 1991).
67. Honghua Li et al., Amplification and Analysis of DNA Sequences in Single Human
Sperm and Diploid Cells, 335 NATURE 414 (1988).
68. Darryl Shibata et al., Fixed Human Tissues: A Resource for the Identification of
Individuals, 36 J. FORENSIC SCI. 1204 (1991); Darryl Shibata et al., Human Immu-
nodeficiency Viral DNA Is Readily Found in Lymph Node Biopsies from Seropositive Individu-
als, 135 AM. J. PATHOL. 697 (1989); and Eric C.J. Claas et al., Human Papillomavirus
Detection in Paraffin-Embedded Cervical Carcinomas and Metastases of the Carcinomas by
the Polymerase Chain Reaction, 135 AM. J. PATHOL. 703 (1989).
69. M.N. Hochmeister et al. Typing of Deoxyribonucleic Acid (DNA) Extracted From
Compact Bone From Human Remains, 36 J. FORENSIC SCI. 1649 (1991).
70. David H. Persing et al., Detection of Borrelia burgdorferi DNA in Museum Speci-
mens ofIxodes dammini Ticks, 249 ScI. 1420 (1990); and David H. Persing, Borrelia, Babe-
sia, Yersinia: Emerging Blood-Borne Pathogens, Paper Presented at the American Society for
Microbiology, Northern California Branch and Northern California Association of Public
Health Microbiologists, 8th Annual Combined Fall Conference (Oct. 1992).
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PCR has been a major factor in the development of the newly-
formed fields of molecular anthropology7 and molecular paleontol-
ogy,72 in which evolutionary relationships between species and the
development of modem organisms are investigated.7" PCR is even
being used to monitor environmental contamination,74 establish the
new medical field of diagnostic molecular pathology,75 and to help
identify those killed in the recent conflict in the Persian Gulf.76 The
tremendous contributions which PCR has made in so many areas
related to molecular biology led to its designation as "Molecule of
the Year" in 1989 by Science, a leading scientific journal.77
B. Technology
PCR is based on a very simple idea. Perhaps the most appro-
priate analogy for PCR is as a genetic photocopy machine.7" The
PCR amplification system simply takes advantage of the natural
DNA replication system and manipulates it to the advantage of the
analyst to produce many millions of DNA copies.
71. David A. Lawlor et al., Ancient HLA Genes From 7,500 Year-Old Archaeological
Remains, 349 NATURE 785 (1991); S. Pidbo et al., Mitachondrial DNA Sequences From a
7000-Year Old Brain, 16 NUCLEIC ACIDS RES. 9775 (1988); S. Pabo, Ancient DNA: Extrac-
tion, Characterization, Molecular Cloning, and Enzymatic Amplification, 86 PRoc. NAT'L
ACAD. ScL USA 1939 (1989); Erika Hagelberg et al., Ancient Bone DNA Amplified, 342
NATURE 485 (1989); Ulf B. Gyllensten & Henry A. Erlich, Ancient Roots for Polymorphism
at the HLA-DQa Locus in Primates, 86 PRoc. NAT'L ACAD. Sd. USA, 9986 (1989); and
Philip E. Ross, Eloquent Remains, Sci. AM., May, 1992, at 115. See also, Thomas J. White et
al., The Polymerase Chain Reaction, 5 TRENDS IN GENETICS 185 (1989); Leslie Roberts, How
to Sample the World's Genetic Diversity, 257 Sci. 1204 (1992)..
72. Jared M. Diamond, Old Dead Rats Are Valuable, 347 NATURE 334 (1991); Svant
Paabo & Allan C. Wilson, Polymerase Chain Reaction Reveals Cloning Artefacts, 334 NA-
TURE 387 (1988); and D. Janczewski et al., Molecular Phylogenetic Inference From Saber-
Toothed Cat Fossils of Rancho La Brea, 89 PROC. NAT'L ACAD. SCI. USA 9769 (1992).
73. Bryan Sykes, The Past Comes Alive, 352 NATURE 381, 382 (1991).
74. Asim K. Bej et al., Detection of Coliform Bacteria in Water By Polymerase Chain
Reaction and Gene Probes, 56 APPLIED ENVTL. MICROBIOL. 307 (1990); Asim K. Bej et al.,
Detection of Escherichia coli and Shigella spp. in Water Using the Polymerase Chain Reaction
and Gene Probes, 57 APPLIED ENVTL. MICROBIOL. 1013 (1991); Asim K. Bej et al., Detection
of Viable Legionella pneumophila in Water By Polymerase Chain Reaction and Gene Probe
Methods, 57 APPLIED ENVTL. MICROBIOL. 597 (1991).
75. W.W. Grody et al., Diagnostic Molecular Pathology, 2 MOD. PATHOLOGY 553
(1989).
76. George W. Clarke, 'Genetic Fingerprinting' Grows as Important Forensic Tool, L.
ENFORCEMENT Q., May-June-July 1991, at 5, 28.
77. Daniel E. Koshland, The Molecule of the Year, 246 Sci. 1541 (1989); Ruth L.
Guyer & Daniel E. Koshland, The Molecule of the Year, 246 Sc. 1543 (1989).
"Like the radio telescope and electron microscope, it represents an advance of a funda-
mental nature." J. Madeleine Nash, Ultimate Gene Machine, TIME, August 12, 1991, at 54,
56.
78. Robert Keeler, Uses for PCR Are Multiplying in Gene-Related Research, 30 RES.
DEV., Aug. 1991, at 30.
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To accomplish this, DNA is extracted from the test sample and
combined with a mixture of the heat-stable DNA polymerase (Taq)
originally obtained from a hot springs bacterium (Thermus
aquaticus) and all of the building blocks necessary for DNA replica-
tion, including nucleotides and primers.79
A machine, such as the Perkin-Elmer thermal cycler, 0 is used
to heat the sample DNA. Heating causes the bonds between the
bases to break, separating the molecule into two strands (the DNA
is "denatured"). This allows the primers to bind ("anneal") to the
complementary sequences on the single-stranded template DNA
strands. DNA polymerase then works from the site of the annealed
primer-template and catalyzes the synthesis of new DNA strands by
linking nucleotides together in the precise order specified by the
template DNA strands. This is termed "extension." The cycle of
denaturation, annealing and extension is then repeated as many
times as necessary to produce the desired number of DNA copies."
Under highly "stringent" conditions, the Taq polymerase is able to
very faithfully reproduce the DNA molecule.8 2 Thus, the amplifi-
79. Primers are segments of DNA with known sequences, designed and produced by
the researcher so that they will bind ("anneal") to the DNA sequences which flank the sec-
tion of DNA of interest in the sample to be amplified. When they are bound to the DNA, the
primers serve as signals for the DNA polymerase to attach to the DNA and begin forming
the complementary strands.
80. The Perkin-Elmer DNA Thermal Cycler is a microprocessor-controlled, thermal
cycling instrument which automates the rapid and precise temperature changes needed in the
PCR process. User-programmable files and preprogrammed protocols can be used. The
sample holding block will accommodate 48 0.5 L microcentrifuge reaction tubes. The tem-
perature range is -50C to 1000C. PERKIN-ELMER CETUS, DNA THERMAL CYCLER 480
SALES BROCHURE 8-9 (1990).
81. In the DQci test kit, the program of denaturation, annealing and extension is re-
peated for 30 cycles. CETUS AMPLiTYPEB HLA DQa FORENSIC DNA AMPLIFICATION &
TYPING KIT, PACKAGE INSERT 13 (undated) [hereinafter AMPLITYPE& PACKAGE INSERT].
82. This works because the hydrogen bonds between incorrectly paired bases (such as
adenine and cytosine, for example) are too weak to withstand the heat. Thus, if the DNA
polymerase made a mistake and tried to pair the wrong base to the parent DNA strand, the
base would "fall off" and either DNA replication would be halted at this point or the correct
base would be added before the DNA polymerase moved on down the molecule.
The rate at which the AmpliTaq& DNA polymerase (the Taq polymerase included with
the DQa test kit) misincorporates nucleotides (inserts an incorrect base while it is extending a
DNA chain) is estimated to be from I per 10,000 to I per 200,000 incorporated nucleotides
per replication cycle.
Using a "worst case" (mutation rate assumptions of I in 10,000, 32 doublings
at 100% efficiency and the fewest number of replicates which can be detected
in the AmpliTyped Kit), no more than I product molecule in 50 could have a
replication error in the region of an allele specific oligonucleotide probe. (A
more reasonable estimate is I molecule in 500, and even this low probability is
based on "worst case" assumptions). The probability of such an error con-
verting one allele to another in a probe region is even lower: even if such an
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cation products truly reflect the content of the original DNA sam-
ple. Prior to the detection steps described below, the amplified
DNA is again denatured. This allows the "oligonucleotide-specific
DNA probes" to bind to complementary sequences which may be
present in the sample of amplified DNA.
Detection of the DNA of interest in the test sample is accom-
plished with these oligonucleotide-specific probes which are com-
posed of DNA strands complementary to those of the DNA of
interest.8 3  In most common test systems, including the Ampli-
TypeO DQca test kit, a "dot" of each probe correlating to the DNA
sequence of each allele under investigation is attached to a nylon
membrane at a distinct location.84 Under suitably stringent condi-
tions, the probe captures complementary amplified DNA; the probe
will not bind to any non-complementary DNA sequences. This
characteristic greatly contributes to the test's high degree of
specificity.
In the DQa test kit and many other test systems, the detection
component is comprised of three molecules-biotin, streptavidin,
and horseradish peroxidase. 5 Biotin is bound to the primers while
the streptavidin and horseradish peroxidase are used together as an
''enzyme conjugate." This conjugate is added during the final steps
of the test procedure. Biotin has an extremely strong affinity and is
highly specific for streptavidin. 6 Thus, if the DNA in the sample
and its attached primer is bound to the probe, the horseradish per-
error were to occur in the first amplification cycle, it would not generate a
detectable signal using this amplification and typing procedure.
CETUS CORPORATION, AMPLITYPE19 USER GUIDE 6-30 (version 2, 1990) [hereinafter USER
GUIDE].
83. Thus, if the sequence in the amplified DNA is ATTCG, the probe sequence will be
TAAGC.
84. This is called a "reverse dot-blot." R.K. Saiki et al., Genetic Analysis of Amplified
DNA With Immobilized Sequence-Specific Oligonucleotide Probes, 86 PROC. NATL. ACAD.
Sci. USA 6230 (1989). In the original DQct test kit, the sample DNA was dotted onto nylon
membrane strips held within individual wells; different solutions, each containing a different
probe was added to each strip. This is called a "dot blot." R.K. Saiki et al., Analysis of
Enzymatically Amplified f-Globin and HLA-DQca With Allele-Specific Oligonucleotide Probes,
324 NATURE 163 (1986); Catherine T. Comey, The Use of DNA Amplification in the Analysis
of Forensic Evidence, 15 CRIME LABORATORY DIG. 99 (1988).
There is an inherently much greater chance of human error involved in the dot blot
procedure. Care must be used to properly and thoroughly label each well and add the correct
probe solutions. In the DQe test kit reverse dot-blot format, the kit is supplied with each of
the probe DNAs bound to membrane strips. Thus, the analyst just needs to add the test
DNA to the strip. While labelling and care should be used with this test also, there are fewer
steps involved, thereby decreasing the amount of manipulation required.
85. Radioactive probes, such as those used for RFLP, are used by some researchers.
86. Meir Wilchek & Edward A. Bayer, The Avidin-Biotin Complex in Immunology, 5
IMMUNOLOGY TODAY 39 (1984). See also, Pennina R. Langer et al., Enzymatic Synthesis of
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oxidase reacts with a soluble, colorless compound te-
tramethylbenzidine (TMB), to produce an insoluble blue product.
The allelic composition of the sample DNA is indicated by the pres-
ence of blue spots on the nylon membrane. In addition to the "test"
spots used to identify the discrete alleles, there is also a "control"
spot which will turn blue if the DQct genes have been amplified.
The intensity of each test dot is compared with that of the control
spot; if the control dot is not present, the test is deemed
unreadable."s
There are several important considerations which must be kept
in mind while developing PCR technology for use in genetic marker
detection in the forensic setting. As listed below, various criteria
have been expounded:
In order to be of maximum benefit to the forensic scientist, a
genetic marker system for forensic PCR analysis should satisfy
the following criteria:
1. The marker should be highly polymorphic and have a high
level of genetic heterozygosity.
2. The target sequence should be easily and specifically
amplified.
3. Methods for detecting allelic variation should be uncompli-
cated and thoroughly reliable.
4. Population data on genotype frequencies must be available in
order to assign estimates of the marker's power of discrimi-
nation and the probability of false inclusion.
5. The marker systems should be inherited independently so
that frequencies derived from one marker system can be
multiplied with those from others, thereby increasing the
power of discrimination. Independent inheritance occurs
when the markers are on separated chromosomes or are in
linkage equilibrium when present on the same
chromosome.88
Presently, there are very few test systems which have been suf-
ficiently developed for forensic use. The most well-known is the
AmpliTypet DQct test kit.8" While AmpliTaq( (the Taq
Biotin-Labeled Polynucleotides: Novel Nucleic Acid Affinity Probes, 78 PROC. NATL. ACAD.
Sci. USA 6633 (1981).
87. See USER GUIDE, supra note 82, at 4-1, Dots with signals less than the "C" dot
should be interpreted with caution.
88. Cecilia H. von Beroldingen et al., Applications of PCR to the Analysis of Biological
Evidence, in PCR TECHNOLOGY: PRINCIPLES & APPLICATIONS FOR DNA AMPLIFICATION
209, 210 (Henry A. Erlich ed., 1989).
89. Another test system used by some companies detects polymorphisms within a re-
lated locus, DQO. This test system takes advantage of many of the same reagents as the DQa
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polymerase) is the subject of patents,' the primer and probe se-
quences are not proprietary.9 1 Thus, unlike the proprietary probes
used in RFLP (e.g., the probes developed by Jeffreys), the sequences
of these molecules are available for any scientist to produce and
test.
In the AmpliTypeT test kit, a specific portion of the human
genome which is known to code for particular structures on white
blood cells ("leukocytes") is amplified and used to "type" the per-
son being studied.92 The human leukocyte antigen system (HLA) is
the area of interest in the AmpliTypeq kit. This kit has been devel-
oped and refined to the point where a trained person can use the
necessary equipment and the reagents provided in the kit, easily fol-
low the established protocol and obtain useful results. Importantly,
this area of the human genome has been extensively studied due to
its role in immune system function.
C. The Human Leukocyte Antigen System (HLA)
The HLA system is composed of proteins (or "antigens")
which are coded for by a large number of genetic loci present on
kit, such as the Taq polymerase and the thermal cycler. Different probes and primers are
used to detect allelic variations within the 13 subunit of the DQ molecule, instead of the Oc
subunit which is the basis of the Cetus DQa test kit.
GeneScreen of Dallas, Texas was the major company utilizing DQ53. Linda Carrico,
Texas' First Forensic Lab Set to Open in Dallas, 4 TEx. LAW. 1 (1989). However, they have
recently switched to the more well-known DQa test kit. Telephone Interview with Robert
Giles, Scientific Director, Gene Screen (Dec. 1991).
90. Taq DNA polymerase and AmpliTaq& DNA polymerase are covered by U.S. Pat-
ent No. 4,889,818, assigned to Cetus Corporation. Cetus is also the assignee of the
GeneAmp@ PCR Process covered by U.S. Patent Nos. 4,683,202; 4,683,195; 4,800,159; and
4,965,188.
91. The probe sequences of the Cetus DQa test kit are published in USER GUIDE, supra
note 82, at Figure 1-4.
92. These structures are called "antigens." Antigens are recognized by antibodies, the
small proteins produced by a sub-group of white blood cells known as B lymphocytes or B-
cells. Antibodies are extremely important in the proper functioning of the immune system
and help the body recognize "foreign" antigens, such as those contained on viruses and bacte-
ria. They also help in the recognition and potential elimination of abnormal tissue cells,
including malignant and senescent cells.
Tissue typing is used to determine which array of antigens are present in the tissue; this
is of utmost importance in transplantation and other medical procedures. If someone re-
ceives an organ from a donor of a different type, it is very likely that the recipient will reject
the transplanted organ, often leading to other complications and death. Therefore, it is very
important that the tissue type of both the donor and recipient be determined before any
transplantation attempts are made. Tissue typing is also often used in paternity investiga-
tions.
Thus, PCR DQoL typing can be considered tissue typing on a genetic level, instead of at
the antigenic level. PCR simply goes straight to the source of the code.
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chromosome #6.13 Due to the large number of allelic variations in
these proteins, there is a large degree of polymorphism.94 The HLA
proteins are divided into two structurally and functionally distinct
groups-Class I and Class 11.9' Within Class II, there are three
families of proteins-DP, DQ and DR.96 Each of these Class II
proteins is composed of two subunits, "a" and "3," which are sepa-
rately encoded in the DNA of each gene cluster. 97 HLA DQA1 is
the gene which codes for the a subunit.98
Within DQa, there are eight different alleles and one
"pseudogene." 99 The "major" alleles, DQA 1, 2, 3 and 4, differ
from one another at many nucleotide positions; they are easily dif-
93. Karen A. Sullivan & Bernard Amos, The HLA System and Its Detection, in MAN-
UAL OF CLINICAL LABORATORY IMMUNOLOGY 835, 835 (Noel R. Rose et al. eds., 1986).
94. Id.
95. Id. at 835-837. The Class I antigens are present on the membranes of most nucle-
ated cells and are recognized as the classical tissue transplantation antigens ("histocompa-
tibility antigens"). Benjamin D. Schwartz, The Human Major Histocompatibility HLA
Complex, in BASIC & CLINICAL IMMUNOLOGY 55, 59 (Daniel P. Stites et al. eds., 5th ed.
1984). The Class II proteins are found on the immune system cells. These proteins are very
important in bone marrow transplantation and autoimmune diseases.
Autoimmune diseases are diseases which are caused by the attack of the body's immune
system on the body itself. Examples of these very destructive diseases include systemic lupus
erythromatosus (SLE), pernicious anemia, rheumatoid arthritis, juvenile diabetes, and others.
JOHN W. KIMBALL, INTRODUCTION TO IMMUNOLOGY 494 (2d ed., 1986); and Henry A.
Erlich & Teodorica L. Bugawan, HLA Class I Gene Polymorphism: DNA Typing, Evolution,
and Relationship to Disease Susceptibility, in PCR TECHNOLOGY: PRINCIPLES & APPLICA-
TIONS FOR DNA AMPLIFICATION 201 (Henry A. Erlich ed., 1989).
96. Sullivan & Amos, supra note 93, at 836.
97. Id.
98. The World Health Organization developed a new nomenclature system for these
antigens. This comment uses the old nomenclature simply to avoid confusion with much of
the literature which also uses the old nomenclature.
The new nomenclature, shown in the table below for the protein, gene and various alleles
associated with the locus, was adapted from WHO, Nomenclature for Factors of the HLA
System, 1989, 31 IMMUNOGENETICS 131 (1990).
Nomenclature used in this review WHO revised nomenclature
Protein DQa DQa
Gene DQaL DQAI
Allele DQA 1.1 DQAI*0101
DQA 1.2 DQAI*0102
DQA 1.3 DQAI*0103
DQA 2 DQAI*0201
DQA 3 DQA 1*0301
DQA 4.1 DQA 1 *0501
DQA 4.2 DQA*0401
DQA 4.3 QA*0601
Pseudogene DXca DQA2
99. Pseudogenes are nonfunctional gene copies which remain in the genome, although
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ferentiated by one probe sequence.' There are also subtypes
within 1 (1.1, 1.2, 1.3) and 4 (4.1, 4.2, 4.3). Although these sub-
types differ from each other by only one or a few nucleotides, they
will all bind with the probe for the major type (i.e., 1.1, 1.2, and 1.3
will all bind with the probe for 1); the I subtypes are distinguished
by using additional probes specific to the correspondingly different
sections for each allele.' ° ' While 4.1, the most common type 4 al-
lele, can be distinguished from 4.2 and 4.3, these other alleles are
relatively rare and are identical to each other in the sequence de-
tected by the AmpliType5 HLA DQcc test system. 102 Therefore,
because 4.2 and 4.3 are not included, the test system only makes use
of the six most important alleles.
Following PCR amplification of the evidence samples, the
DQa types are compared. If the DQct genotype of the suspect is
different from that of the evidence sample, the suspect is "excluded"
and cannot be the donor of the evidence. Unlike matches or inclu-
sions, exclusions are independent of the frequencies of the genotype
in the population.' 013
If the suspect and evidence have the same genotype, then the
suspect is "included" as a possible source of the evidence sample.
The probability that another, unrelated individual would also
match the evidence is equal to the frequency of that genotype in the
relevant population. Multiple studies have been conducted to deter-
mine the genotype frequencies in various ethnic and geographically-
defined population groups; significant differences were observed be-
tween the ethnic groups examined.' 0 4
they may have recently lost their function in evolution. See, USER GUIDEsupra note 82, at I-
3.
100. R. Saiki et al., Genetic Analysis ofAmplified DNA With Immobilized Sequence-Spe-
cific Oligonucleotide Probes, 86 PROC. NAT'L ACAD. SC. USA 6230 (1989).
101. USER GUIDE, supra note 82, at 1-3.
102. Id.
103. Id. at 5-1.
104. In a recent study, over 1400 individuals were typed using both the dot-blot and
reverse dot-blot methods to determine the DQa genotypes for 11 population groups. The
observed frequencies of DQa genotypes did not significantly deviate from those expected on
the assumption of Hardy-Weinberg equilibrium. There was a slight excess of homozygotes in
one Hispanic (denoted by "Spanish sumame") and one Southeast Asian group which was
found to be consistent with the heterogeneity of these groups. These data indicate that the
HLA-DQa marker system is useful in individual identification because genotype frequencies
can be reliably estimated from allele frequency data. Rhea Helmuth et al., HLA-DQx Allele
and Genotype Frequencies in Various Human Populations, Determined Using Enzymatic Am-
plification and Oligonucleotide Probes, 47 AM. J. HUM. GENETICS 515 (1990).
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D. Population Genetics and the DQcx Level of
Discrimination
As stated above, in order to develop PCR kits, (e.g., Ampli-
Typel), it is necessary to identify all of the possible alleles which
could be present at the locus of interest, determine their DNA se-
quences and then study large populations to determine the frequen-
cies of each allele and genotype for various ethnic groups.10 5 These
population genetics data are used to determine the statistical
probabilities that a certain person within a particular racial group
will have a particular combination of HLA DQct alleles. As dis-
cussed in more detail below, the DQcx system is more discriminating
than any of the traditional genetic markers used in forensics. 0 6
For example, each person has two DQA alleles (one contrib-
uted from each parent) and there are a total of six alleles detected in
the AmpliTypeO system. Thus, there are 21 potential genotypes
which may be detected. The frequencies of these genotypes range
from less than 0.0005 to 0.15.107 The discriminating power (DP) of
the DQct typing system is 0.93.108 This compares favorably with
the discriminating power of the ABO red cell typing system (DP =
0.60), and analysis of the isozyme PGM (phosphoglucomutase) (DP
= 0.76).'09 From these numbers, it is evident that, by itself, PCR
DQat typing can neither provide individual identification nor
achieve the phenomenally high numbers generated by RFLP meth-
ods. However, it has proved useful in conclusively including or ex-
cluding criminal suspects in circumstances where conventional
typing has failed or insufficient DNA was available for RFLP." 0
There are some distinct advantages to PCR over RFLP. Un-
like presently used RFLP systems, it is an allele-specific system
which identifies a discrete trait inherited in a clear Mendelian fash-
ion. The distinctness and permanence of the DQca allelic variants is
clearly demonstrated by their maintenance over millions of years."'
Comparison of the observed genotype frequencies with the Hardy-
105. Id.; See also, Sara A. Westwood & David J. Werrett, An Evaluation of the Polymer-
ase Chain Reaction Method for Forensic Applications, 45 FORENSIC SCI. INT'L 201 (1990).
106. George F. Sensabaugh & Cecilia von Beroldingen, The Polymerase Chain Reaction:
Application to the Analysis of Biological Evidence, in FORENSIC DNA TECHNOLOGY 63, 72
(Mark A. Farley & James J. Harrington eds., 1991).
107. von Beroldingen et al., supra note 88, at 212.
108. Discriminating power is the probability of distinguishing between two randomly
selected individuals from all of the populations studied.
109. Sensabaugh & von Beroldingen, supra note 106 at 212.
110. See, e.g., People v. Quintanilla, No. C-23691 (San Mateo Superior Ct., Aug. 16,
1991). For a discussion of this case, see supra note 8.
111. Gyllensten & Erlich, supra note 71.
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Weinberg expected frequencies can help validate typing methods--
an excess of homozygosity would reveal a population substruc-
ture. 112 The close fit between the observed and expected DQoL geno-
type frequencies affirms the typing methodology and genetic model.
Thus, although the discrimination power for the DQca marker
system is less than that for most RFLP systems, it is a simple and
rapid method which is capable of analyzing minute and degraded
samples. As more PCR-based markers are researched and become
readily available, a panel of tests will likely be developed which, in
addition to the exclusionary value already provided by the DQct
system, will provide valuable information for individual inclusions.
Alone, the AmpliTypel system for DQci provides a power of
discrimination of approximately 83 to 94%. 113 However, because
the DQct alleles are inherited independently from the conventional
marker systems, results can be combined to increase the overall
power of discrimination. Thus, combining the individualization po-
tentials for DQa, ABO, PGM and secretor status in a typical sexual
assault case increases this power of discrimination to 99%.11
4
The following table is from an informational flyer provided by
Cetus, which illustrates how DQcL test results can be presented in
court in conjunction with results from conventional genetic marker
typing in a typical sexual assault case.
112. Helmuth et al., supra note 104, at 521.
The assumption of Hardy-Weinberg equilibrium allows estimation of genotype frequen-
cies from observed allele frequencies and makes high levels of individual discrimination possi-
ble from relatively limited population data. For many VNTR (variable number tandem
repeat) or RFLP systems, the discrimination of alleles is limited by gel electrophoresis resolu-
tion. A great excess of homozygotes may be found in VNTR population samples. Eric
Lander, DNA Fingerprinting on Trial, 339 NATURE 501 (1989). The inability to fully dis-
criminate classes due to limitations of the typing methodology and potential subpopulation
structure may contribute to an excess of homozygotes. High mutation rates in some VNTR
systems also creates the expectation of homozygote excess (up to 5%). Alec Jeffreys et al.,
Spontaneous Mutation Rates to New Length Alleles at Tandem Repetitive Hypervariable Loci
in Human DNA, 332 NATURE 278 (1988).
113. Helmuth et al., supra note 104, at 520.
114. See Sensabaugh, Biochemical Markers of Individuality, in FORENSIC SCIENCE
HANDBOOK 338-415 (Richard Saferstein ed., 1982).
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ABO/Secretor
Sample Status PGM HLA DQa
VictimReceBo 0 Secretor 1 + 1.2,1.2Reference Blood
1.3,2 (Sperm)
Vaginal Swab A & H Activity 1+1- 1.2,1.2
(Epithelial cells)
Questioned Hair
From Victim's Not Done Not Done 1.3,2
Pubic Combing
Suspect
Reference Blood A Secretor 1 + 1- 1.3,2
The results in the above hypothetical case indicate that the sus-
pect cannot be excluded because the semen contributor is an ABO
Type A Secretor with PGM type 1 + 1- or 1- activity and DQct
type 1.3,2. Without including DQoL gene frequency information,
this combination of types occurs in approximately 7% of the white
population." 5 But, if DQca gene frequency information is included,
the combination of types occurs in approximately 0.09% of the
white population."I6 Furthermore, the suspect is also not excluded
as the source of the questioned pubic hair. DNA extracted from the
hair root was 1.3,2, which is consistent with the DQct type of the
suspect. This DQca genotype occurs in approximately 1.9% of the
white population, a genotype frequency less common than that of
the conventional ABO, PGM and secretor systems combined.
Recognizing the great potential in combining PCR with RFLP
or direct sequencing, many researchers are studying the possibili-
ties.1 7 The combination of PCR and RFLP affords a greater detec-
tion sensitivity than can be achieved by the RFLP method alone
and greater discrimination than can be achieved by PCR alone."'
This is a very powerful combination of methods which could result
115. B.W. Grunbaum et al., Distribution of Genetic Frequencies and Discrimination
Probabilities for 22 Human Blood Genetic Systems in Four Racial Groups, 25 J. FORENSIC
Sd. 428 (1980).
116. Id.
117. K. Kasai et al., Amplification of VNTR Locus (pMCTI18) by the Polymerase Chain
Reaction (PCR), 1989 PROC. INT'L SYMP. FORENSIC ASPECTS DNA ANALYSIS 279 (1989);
Bruce Budowle et al., Analysis of the VNTR Locus D1S8O by PCR Followed by High-Resolu-
tion PAGE, 48 AM. J. HUM. GENETICS 137 (1991); David R. Engelke et al., Direct Sequenc-
ing of Enzymatically Amplified Human Genomic DNA, 85 PROC. NAT'L ACAD. SCI. USA 544
(1988).
118. See, Bruce Budowle et al., Review Article: An Introduction to the Methods of DNA
Analysis Under Investigation in the FBI Laboratory, 15 CRIME LABORATORY DIG. 8,18
(1988). Also see, Proceedings of the International Seminar on the Forensic Application of PCR
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in another generation of DNA typing methods." 9
E. Perceived Problems Associated with PCR
In addition to the low level of discrimination, as discussed
above, there are several perceived problems with PCR. However,
while some of these problems are of valid concern, others appear to
be make-weight legal arguments against the use of the technology.
Concerns voiced in the literature and cases include:
(1) "allelic drop-out";
(2) the sensitivity of the test and the potential for
contamination;
(3) the small number of laboratories conducting the test; and
(4) interpretation problems.
1. "Allelic Drop-Out"
This is a term which has been used to describe differential or
preferential amplification, the situation in which the procedure
greatly favors one of the two alleles present in a heterozygous indi-
vidual such that the results would lead one to wrongly conclude
that the individual was homozygous at the locus examined.'
However, there is no scientific basis for the belief that differential
amplification occurs in the AmpliTypeI system.
First, there is no evidence that selective priming for some al-
leles relative to other alleles occurs in the AmpliType5 system.' 2'
However, an alternative explanation is that there is selective dena-
turation of some alleles relative to others. An experiment was con-
ducted on DNA from a DQa 1.1,4 heterozygote to determine
whether selective denaturation occurs.122 At 90°C or above, there
Technology, 18 CRIME LABORATORY DIG. (1991), and Bruce Budowle, AMP-FLPs: Genetic
Markers for Forensic Identification 18 CRIME LABORATORY DIG. 134 (1991).
119. Amplified restriction fragment length polymorphisms (AmpFLPs) are recently de-
veloped test systems in which a DNA sample too small for conventional RFLP analysis is
first amplified and then tested by RFLP. G.T, Hom et al., Amplification of a Highly
Polymorphic VNTR Segment by the Polymerase Chain Reaction, 17 NUCLEIC AcIDs RES.
2140 (1989); E. Boerwinkle et al., Rapid Typing of Tandemly-Repeated Hypervariable Loci by
the Polymerase Chain Reaction: Application to the Apolipoprotein B 3' Hypervariable Region,
PROC. NAT'L ACAD. Scl. 212 (1989). A test kit for DISS0 is currently available. This kit
may become the first AMP-FLP kit used for forensic purposes. See Kasai et al., supra note
28, and Y. Nakamura et al., Isolation and mapping of a polymorphic DNA (pMCTII8) on
chromosome ip (Dis80), 16 NUCLEIC AcIDs RES. 9364 (1988). This method not only takes
advantage of the exquisite sensitivity of PCR, but it also minimizes the problems of bacterial
DNA contamination, and increases the quantity of sample DNA so that RFLP is possible.
120. USER GUIDE, supra note 82, at 6-24.
121. Id. See also Gyllensten & Erlich, supra note 71.
122. The sequences of DAQ 1.1, 1.2 and 1.3 alleles significantly differ from the DQA 2,3,
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was consistent typing of DQc 1.1 and 4. Below 88°C, neither allele
amplified nor typed. However, at 88°C, the results reflected prefer-
ential amplification of DQA 4 as compared to DQA 1.1 (DQA 4
allele could be amplified, but not DQA 1.1). These results are based
on the ability of the DQA 4 allele to be denatured and serve as a
template at this low temperature.
Therefore, preferential amplification and hence, allelic drop-
out is a possibility if the temperature of the reaction is substantially
below the specified temperature of 94°C. If the temperature of the
thermal cycler wells is close to 94°C during denaturation, preferen-
tial amplification and "allelic dropout" should not occur.' 23 Thus,
this important study indicated that the phenomenon is possible, but
improbable, as long as the equipment is properly calibrated and
maintained. Therefore, as an additional control, the kit presently
on the market contains a heterozygous human genomic DNA con-
trol of DQct type 1.1,4.
Also, the population genetics data do not reveal an excess of
homozygotes which would be attributable to some hypothetical
"blank" or "null" allele that might fail to amplify.' 2 In addition,
as the oligonucleotide primers are capable of amplifying a specific
DQct fragment from many different primate species, the sequences
to which the primers are complementary are highly conserved in
evolution. 2 ' Thus, allelic drop-out is a "non-problem" which a
proponent of PCR evidence should be able to discuss if the oppo-
nent of the evidence brings it up.
2. Sensitivity and Contamination
The exquisite sensitivity of PCR is both its blessing and its
curse. PCR has the capability to amplify the DNA present in a
single hair root,' 26 including several-month-old fallen hairs in
and 4 alleles in that they have a higher GC to AT base pair ratio. USER GUIDE, supra note
82, at 6-24. This is significant in denaturation because there are three hydrogen bonds be-
tween GC pairs and only two bonds between AT pairs. See LEWIN, supra note 9, at 17.24.
Thus, higher temperatures (more energy) are required to break GC bonds than AT bonds.
The experiment was designed to determine whether, under non-standard conditions, prefer-
ential amplification occurs due to the selective denaturation of some alleles.
123. USER GUIDE, supra note 82, at 6-24.
124. Helmuth et al., supra note 104, at 520.
125. Gyllensten & Erlich, supra note 71.
126. Russell Higuchi et al., DNA Typing From Single Hairs, 332 NATURE 543 (1988). In
this publication, the authors indicate that the DNA in hair is often limited and/or degraded.
Id. at 544. This does not appear to be a major problem for PCR, but would preclude the use
of RFLP.
The use of hair samples has various advantages over the use of blood. Some suspects
may be unwilling to provide blood for testing due to their religious beliefs or customs. In
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which DNA was not detectable by the usual chemical methods
(representing less than 1 ng DNA). 27 This is of particular signifi-
cance because hair is one of the most frequently found forms of
biological evidence at crime scenes.' 2 '
Given this extreme sensitivity, one major concern is that "con-
taminating" DNA present in the sample will be amplified and com-
pletely mask the true DNA of interest. 129 However, there are many
routes by which such contaminating DNA may be avoided, de-
tected and/or eliminated. Nonetheless, a justifiable concern is that
forensic samples are relatively rarely pure (with the exception of
blood collected by venipuncture).
There are many potential sources of contaminating DNA, in-
cluding DNA contributed by the victim, bystanders, the analyst, or
even other organisms. There is also the concern that previously am-
plified DNA will contaminate the test DNA sample as it is being
processed within the lab.' 30
Contaminating DNA From Species Other Than Humans. The
DQa test system is designed with very specific primers and probes.
In numerous tests, it was established that only primate DNA is am-
plified in this test system. 3 ' DNA from dogs, cats, bacteria, viruses
and other organisms will not be amplified nor even detected.' 32
Thus, unless a chimpanzee or gorilla is involved in a crime scene,
some situations, transport of blood is impractical. In the veterinary setting, hair samples may
be much easier to get than blood. This could be very important in endangered species pro-
grams where the risk of stress and/or anesthesia used during blood collection may be too
great. Collection of hair samples makes it much easier to get the information desired, but
with the least impact upon the animal. Also, if the animal is dead, blood may not be avail-
able, making hair the sample of choice.
See also, Rieko Uchihi et al., Deoxyribonucleic Acid (DNA) Typing of Human Leukocyte
Antigen (HLA)-DQA1 From Single Hairs in Japanese, 37 J. FORENSIC Sci. 853 (1992).
127. Higuchi et al., supra note 126, at 545.
128. RICHARD E. BISBING, THE FORENSIC IDENTIFICATION AND ASSOCIATION OF
HUMAN HAIR 185 (Richard Saferstein ed., 1982).
129. See, Russell Higuchi & Edward T. Blake, Applications of the Polymerase Chain Re-
action in Forensic Science, BANBURY REP. 32: DNA TECH. AND FORENSIC SCI. 265, 273
(1990)
130. S. Kwok & R. Higuchi, Avoiding False Positives with PCR, 339 NATURE 237, 237
(1989); Eden Fisher & David R. Lincoln, 7 RECOMBINANT DNA TECH. BULL. 1 (1984); J.
Fenton Williams, 7 BIOTECHNIQUES 762, 767 (1989); and Richard A. Gibbs & Jeffrey S.
Chamberlain, The Polymerase Chain Reaction: A Meeting Report, 3 GENES & DEVELOP-
MENT 1095, 1097 (1989).
131. USER GUIDE, supra note 82, at 6-27; Cetus Corporation, Background Information:
Polymerase Chain Reaction-PCR Technology, Nov. 1987; and Cetus Corporation, Forensic
Analysis By the Polymerase Chain Reaction (PCR), CETUS BACKGROUNDER, Feb. 1990.
132. USER GUIDE, supra note 82, at 6-27. Also, while amplified DNA from chimps and
gorillas will hybridize to the probes, amplified DNA from more distantly related primates
does not hybridize. See also Gyllensten & Erlich, supra note 71.
2003] BIOTECHNOIOGY / LIFE SCIENCES LAW 125
1993] POL YMERSE CHAIN REACTION 317
there is no danger that non-human DNA will be amplified or de-
tected by this test.
Contaminating DNA From "Extraneous" Humans. One con-
cern voiced by some commentators is that, unlike the "pristine"
medical setting in which pure samples are supposedly ensured, fo-
rensic samples often contain DNA from more than one person.'3 3
However, while mixed samples are probably the norm for fo-
rensic samples, anyone who has worked in a hospital can attest that
the medical environment is anything but pristine, and pure samples
are sometimes impossible to obtain. A prime example of this is
amniocentesis, in which samples contain cells contributed by the
mother as well as by the fetus. Another example involves the detec-
tion of cancerous' 34 or HIV-infected cells,' 35 where the entire point
of the test is to identify the few malignant or infected cells hidden
within a large population of normal cells. A third example is the
detection of HIV- 1 in discarded needles.' 136 It would seem very dif-
ficult to argue that these three situations reflect the "large," and
"clean" samples many commentators associate with the use of PCR
and other DNA techniques in medical and research labs.' 37 Con-
trary to the depiction by one commentator that "scientists analyze
fresh, hygienic and relatively unlimited amounts of DNA,"' 38
clinical and research laboratories often must work with small quan-
tities of contaminated samples which are not necessarily "fresh" nor
133. Peter J. Neufeld & Neville Colman, When Science Takes the Witness Stand, Sci.
AM. May 1990, at 46; Simon Ford & William C. Thompson, A Question of dentity, 4 CAL.
DEFENDER No. 3 42, 43 (undated); Anthony Pearsall, Comment, DNA Printing: The Unex-
amined "Witness" in Criminal Trials, 77 CAL. L. REV. 665 (1989); Stephen C. Petrovich,
DNA Typing: A Rush to Judgment, 24 GA. L. REV. 669 (1990); William C. Thompson &
Simon Ford, DNA Typing: Acceptance and Weight of the New Genetic Identification Tests, 75
VA. L. REV. 45 (1989) [hereinafter DNA Typing]; William C. Thompson & Simon Ford, Is
DNA Fingerprinting Ready for Trial? (An Update), 4 CAL. DEFENDER No. 3, 36 (undated);
C. Thomas Blair, Comment, Spencer v. Commonwealth and Recent Developments in the Ad-
missibility of DNA Fingerprint Evidence, 76 VA. L. REv. 853 (1990); Hoeffel, supra note 1;
Michael Damore, What Every Criminal Lawyer Should Know, 27 CRIM. L. BULL. 114, 116-
117 (1991).
134. This includes detection of human papillomavirus infection, a risk factor for develop-
ment of squamous and glandular neoplasia of the genital tract. Marion T. Cornelissen et al.,
Localization of Human Papillomavirus Type 16 DNA Using the Polymerase Chain Reaction in
the Cervix Uteri of Women with Intraepithelial Neoplasia, 70 J. GEN. VIROLOGY 2555 (1989).
135. Winand Lange et al., Detection by Enzymatic Amplification of ber-abl mRNA in
Peripheral Blood and Bone Marrow Cells of Patients with Chronic Myelogenous Leukemia, 73
BLOOD 1735 (1989); PCR Profiles: Polymerase Chain Reaction in Situ, AMPLIFICATIONS
Mar. 1990 at 20. See also, Ou, supra note 58.
136. Stephen Raffanti et al., Determination of HIV-1 Status of Discarded Sharps:
Polymerase Chain Reaction Using Minute Quantities of Blood, 264 JAMA 2501 (1990).
137. Thompson & Ford, supra note 133, at 36, 38; Pearsall, supra note 133, at 671.
138. Pearsall, supra note 133, at 671.
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"hygienic." It is also very difficult to argue that some settings in
which PCR has found widespread use provide large and clean sam-
ples (e.g., molecular anthropology and paleontology).
If medical science can cope with potentially significant "con-
tamination" problems, it is reasonable to believe that contamination
problems may be just as effectively dealt with in the forensic setting.
Indeed, this has been recently and conclusively established in two
cases, one involving the rather gruesome disappearance of a
child,' 39 and the other involving identification of a murder victim
from 8-year old skeletal remains." ° The tidbits of human tissue
mixed among corn silage and the skeletal remains exposed to the
elements for eight years were amenable to the PCR analysis which
answered the questions asked in these two cases. Thus, it is highly
likely that PCR will continue to be used in similar cases where van-
ishingly small quantities of sample are available, as well as in cases
where the species of the sample source must be determined.' 4 ' PCR
may also prove useful in cases in which there may be a question of
whether the blood present in an evidence sample was contributed by
a human or some other animal.
The FBI conducted an extensive validation study on the effects
of induced contamination and sample handling on the ability to per-
form PCR analysis.'42 The study included dried or moist stains put
together, blood mixed with perspiration stains on a shirt, blood-
stains which were physically handled, contaminated by exposure to
aerosols created by coughing, mixed with shed scalp tissue, and
placed in contact with contaminated scissors, and blood that was
139. The 2-year old daughter of two farm laborers was reported as missing during the
corn harvest. Unidentifiable tissues were subsequently found among the silage. Samples
from the parents and the recovered tissues were tested with both RFLP and the DQe test
system. The DNA results indicated that the tissue recovered from the silage was human and
confirmed the probable parentage of the two farm workers. P. Mulhare et al., An Unusual
Case Using DNA Polymorphisms to Determine Parentage of Human Remains, 12 AM. J. FO-
RENSIC MED. PATHOLOGY 157 (1991).
140. Enka Hagelberg et al., Identification of the Skeletal Remains of a Murder Victim by
DNA Analysis, 352 NATURE 427 (1991).
141. For example, this could be of great importance in the prosecution of wildlife
poachers and importers of endangered species. PCR methods (not HLA DQrs) may be devel-
oped to identify which species or subspecies a particular confiscated steak, pelt or mounted
trophy belongs. For a discussion of how RFLP is already in use for such purposes, see
KIRBY, supra note 1t, at 233-259. For a brief description of the laboratory most likely to use
DNA typing in such circumstances, the National Fish and Wildlife Forensics Laboratory in
Ashland, Oregon, see Thomas Brom, All God's Creatures, CAL L., Dec. 1991, at 44-45. A
recent article describes the development of probes suitable for use in wildlife forensic science.
R.S. Blackett & P. Keim, Big Game Species Identification by Deoxyribonucleic Probes, J. Fo-
RENSIC SCI. 590 (1992).
142. C.T. Comey & B. Budowle, supra note 43.
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mixed with other substances such as saliva. 143 No detectable con-
tamination was found to be introduced by handling, coughing, or
the presence of perspiration. Likewise, the two moist stains placed
in contact with each other and allowed to dry did not cross-contam-
inate. However, the mixture of saliva and blood equal amounts
apeared to result in a combined HLA-DQca phenotype; the salivary
phenotype appeared to be stronger, probably due to the presence of
a large number of epithelial cells."'
3. Small Number of Forensic Laboratories Using the
Test
The small number of forensics laboratories using the test has
been a factor for some courts which have excluded PCR evi-
dence.14 As of March 1991, Cetus reported that over 30 forensic
labs were performing DQct typing. 46 Given the capital outlay re-
quired to begin PCR analysis, it is not too surprising that more labs
have not started using the technology.'4 7 In addition, there are
costs of training personnel in the proper use of the methods. 4
Sending samples to an outside laboratory is also expensive.'4 9
Although there are probably many labs who would like to have the
capability of using PCR, most of them are unlikely to have the nec-
essary resources available in these lean economic times. 50
In view of the advantages presented by PCR as compared with
143. Id.
144. Id.
145. People v. Mack, No. 861116 (Sacramento Super. Ct. 1991).
146. Cetus Corporation, Attorney/Investigator Slide Presentation of Forensic DNA Analy-
sis Methods (unpublished manuscript) [hereinafter Slide Presentation]. In comparison, over
50 forensic labs were "capable" of performing RFLP as of the same date. Id.
147. In March 1991, Cetus estimated the total purchase price for all the new capital
equipment necessary for PCR analysis to be $15,000 to $20,000 for a typical crime lab. How-
ever, this is comparatively inexpensive, as RFLP capital equipment costs are estimated at
approximately $150,000 to 200,000. Id.
148. In 1991, the cost of a one week training course at Cetus was $1000. Id.
149. In June 1989, DNA testing ranged from $325/sample at Lifecodes to $490/sample
at Cellmark to $1 500/case at Forensic Science Associates. The expert witness fees (daily rate
plus expenses) ranged from $1,000/day for a Ph.D. or $750/day for a non-Ph.D. from
Cellmark, $100-$125/hour for Forensic Science Associates and $750/day for Lifecodes. OF-
FICE OF TECHNOLOGY ASSESSMENT, U.S. CONGRESS, OFFICE OF TECHNOLOGY ASSESS-
MENT, GENETIC WITNESS: FORENSIC USES OF DNA TESTS 25 (1990) [hereinafter GENETIC
WITNESS].
150. The FBI's report on forensic DNA testing indicates that many labs would be inter-
ested in conducting DNA analysis, but lack of necessary personnel, insufficient space or
equipment, insufficient budget resources, and insufficient caseload or local demand for DNA
testing fail to justify establishing a DNA laboratory. The lack of or difficulty in obtaining a
Nuclear Regulatory Commission (NRC) license for handling radioactive materials, the
length of time required to become operational and the unavailability of DNA testing training
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RFLP, it would be very useful if this analysis was available in every
crime lab. Most cases do not require the sophisticated techniques,
sometimes difficult interpretations and astronomical numbers gen-
erated by RFLP. In most cases, it would seem likely that PCR in
combination with other serological markers would provide a quick,
relatively inexpensive and very reliable yes/no (inclusion/exclusion)
answer.
15 1
4. Interpretation Problems
Some witnesses have testified to discrepancies in the reading of
the dot blots. However, these concerns have largely been negated
by the inclusion of a "control" dot on the probe strips. This is be-
cause in order for the test to be deemed "readable," the intensity of
color at a test dot must be at least as intense as that of the "All
Control."'5 2 Thus, if the "all control" (C) dot is more intense than
the other dot, it is an indication that the results need careful
analysis.
Sexual Assault Evidence Samples. In forensic DNA PCR anal-
ysis, sexual assault evidence samples are often involved. Usually,
these are the archetypal mixed samples, typically containing a
sperm cell component contributed by the male rapist and vaginal
epithelial cells contributed by the female victim. Techniques such
as "differential lysis" have been developed, which allow good sepa-
ration between the sperm and epithelial cell fractions.'5 3
Differential lysis takes advantage of the physical and biochemi-
cal characteristics and differences between the relatively resistant
sperm cells and the relatively fragile epithelial cells. Epithelial cells
will lyse (burst) under conditions which are much less harsh than
those required to lyse sperm. Thus, by lysing the epithelial cells and
centrifuging the sample to physically separate the sperm from the
epithelial DNA now present in suspension on the top of the sperm
were other concerns. Jay V. Miller, The Outlook for Forensic DNA Testing in the United
States, 17 CRIME LABORATORY DIG. I (Supp. 1) (1990).
151. PCR analysis can be completed within a few days, while RFLP often requires weeks
of work. Slide Presentation, supra note 146, at 15.
152. The "C" dot is the weakest on the strip. If it is absent, an accurate determination of
the type cannot be made. This is because there may be other probe signals below the thresh-
old of detection. The "C" dot provides assurance that the appropriate typing and sub-typing
dots should be clearly visible. If visible dots with signal intensities less than the "C" dot are
present, this is an indicator of possible procedural error, mixed samples, DNA contamination
or the presence of DXat, DQa type 1.3,4, or subtypes of the DQA 4 allele. USER GUIDE,
supra note 82, at 4-1. The package insert also contains a useful section on troubleshooting.
Id. at 29-34.
153. Giusti et al., supra note 46; and USER GUIDE, supra note 82, at 3.18 to 3.19.
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fraction, the DNA from the victim may be harvested from the evi-
dence sample. In subsequent steps, the sperm are lysed and the rap-
ist's DNA is harvested.
In a typical sexual assault case, many samples are tested simul-
taneously. "Mixed" evidence samples, such as those from vaginal
swabs or semen stains on the victim's clothes, are tested along with
"pure" DNA collected from both the suspect and the victim, and
the sperm cell and epithelial cell fractions are isolated from a por-
tion of the "mixed" evidence sample. By testing all of the various
combinations of the above samples, along with samples from any
other person who may have contributed DNA to the evidence (e.g.,
sperm contributed by the victim's boyfriend if he had intercourse
with the victim prior to the sexual assault) will allow determination
of the allelic composition of each sample. Because each person only
has two alleles, a maximum of two alleles should be identified in
each sample. However, if the sample is mixed, it is very likely that
three or more alleles will be detected. Of course, if the two people
share the same DQct type, there will still only be two alleles identi-
fied, even if the sample is "mixed." However, they will also be
found to have the same type in their "pure" samples. Thus, there
are internal controls within the test methodology which help ensure
that the results obtained by the laboratory are correct and reliable.
Nonetheless, these results simply mean that the suspect can neither
be included nor excluded from the pool of potential suspects based
on PCR DQct typing. Other means of identification and other types
of evidence will probably be required for conviction. 5 4
Other Sample Types. Mixed samples may also be found in
bloodstains and other biological evidence. In this case, it becomes
even more important to test "pure" samples from both the victim
and the suspect. Differential lysis will not work in this situation, as
there is no significant difference in the resistance to harsh environ-
mental conditions of blood cells obtained from different people.
While mixed samples are very common, there are numerous
legal circumstances in which "pure" DNA samples are available.
These include paternity determinations'55 and cases involving the
identification of murder victims. 56 The expense of DNA testing is
154. USER GUIDE, supra note 82, at 4-6 to 4-8.
155. See B.P. Ludes et al., Parentage Determination on Aborted Fetal Material Through
Deoxyribonucleic Acid (DNA) Profiling, 36 J. FORENSIC SCI. 1219 (1991).
156. Akane et al., supra note 57; Yvonne Baskin, DNA Unlimited, DISCOVER, July 1990,
at 77; Cetus Corporation, supra note 57; Jeremy Cherfas, Genes Unlimited, NEW SCIENTIST,
April 1990, at 29; Forensics Experts Tackle Task of Identifying Thousands of 'Disappeared'
Victims, 261 JAMA 1388 (1989); Hagelberg et al., supra note 140; Lawrence Kobilinsky &
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particularly justified when corroborating evidence in difficult cases
is needed to help convince the jury of the suspect's guilt or inno-
cence. However, it is unlikely to supplant the other major identifi-
cation test systems such as fingerprint analysis, red cell typing (e.g.,
ABO), and other methods commonly used to identify a suspect as
the perpetrator of a crime. It is most probable that PCR will be
used as an adjunct test in combination with other evidence and
analyses to help bolster a case and ensure either a conviction or an
acquittal.
F. Laboratory Design and Test Protocols
This section highlights additional aspects of DNA testing
which attorneys must keep in mind. While attorneys involved in
DNA cases must understand the technology to a certain extent,
they also must have an awareness of laboratory set-up and proce-
dures. It is important for the legal community to realize that labo-
ratory design and test protocols are potentially significant aspects of
the tests which may need to be addressed in court.
It is highly advisable for attorneys to be extremely familiar
with the laboratory and the person who conducted the tests on the
evidence. Thus, if the opponent to the test procedure raises issues
regarding contamination, the well-prepared proponent of the evi-
dence should be able to counter the arguments with specific descrip-
tions, photographs or other documentation of the care and diligence
with which samples are handled and tested in the laboratory. On
the other side of the fence, if the opponent of the evidence is aware
of sloppy technique, the lack of controls and/or unsuitable labora-
tory design which could foreseeably lead to contamination, this
would be an important argument against the evidence.
Because laboratory design and test protocols play potentially
very significant roles in the success of DNA testing conducted in a
particular facility, the laboratory and test protocols should be estab-
lished with the potential contamination problems in mind. Envi-
Louis Levine, Recent Application of DNA Analysis to Issues of Paternity, 33 J. FORENSIC SCI.
1107 (1988); Henry C. Lee et al., Genetic Markers in Human Bone. I Deoxyribonucleic Acid
(DNA) Analysis, 36 J. FORENSIC Sci. 320 (1991); Henry C. Lee et al., DNA Analysis in
Human Bone and Other Specimens of Forensic Interest: PCR Typing and Testing, 31 J. Fo-
RENSIC SCI. Soc'Y 213 (1991); Roger Lewin, A Matter of Maternity, 233 Scl. 522 (1986); B.P.
Ludes et al., Parentage Determination on Aborted Fetal Material Through Deoxyribonucleic
Acid (DNA) Profiling, 36 J. FORENSIC SCI. 1219 (1991); J. Madeleine Nash, Ultimate Gene
Machine, TIME, August 12, 1991, at 54; Schwartz et al., supra note 44; and Darryl Shibata et
al., Fixed Human Tissues: A Resource for the Identification of Individuals, 36 J. FORENSIC
Sci. 1204 (1991).
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ronmental contamination from within the laboratory may result
from the introduction of DNA from the analyst, another unampli-
fled sample or a previously amplified sample. Although these pres-
ent important considerations, good laboratory practice will
overcome them.'" 7 Gloves should be worn at all times, masks
should be worn by laboratorians working with samples, aerosols
should be minimized, and sample tubes should be tightly closed
when not in use.158
To prevent the transfer of DNA from one sample to another,
extra precautions should be taken during the DNA extraction and
PCR setup steps. Simple precautions such as using a fresh pipette
tip for each sample, carefully opening reaction tubes, and keeping
the tubes closed when they are not being used will prevent this type
of contamination.' 59 The DNA extraction and PCR setup of evi-
dence samples should be done at a separate time from the DNA
extraction and PCR setup of reference samples to prevent cross-
contamination. 60 It is also recommended that DNA extraction of
samples containing high levels of DNA (e.g., whole blood) be con-
ducted separately from samples with low DNA levels (e.g., single
hairs, small bloodstains, etc.). 161
Laboratory design features and strict adherence to recom-
mended methods will avoid the problem of "carry-over" (contami-
nation of a sample with amplified DNA from a previous PCR
reaction). Carryover contamination is a major concern because am-
plification product is an ideal substrate for subsequent
amplifications.
A single PCR reaction produces an enormous number of copies
(as many as 10"s) that can potentially contaminate samples yet to
be amplified. Since the number of copies of amplified DNA in a
completed PCR reaction is so high, inadvertent transfer of even a
minute volume to a yet to be amplified sample by splashing or
aerosol may result in the amplification and typing of the "con-
taminating" DQa sequence. For example, if reusing a pipette tip
transfers 0.1 1iL, this can be as many as 10 0 copies of amplifiable
sequence. By comparison, a microgram of human genomic
DNA contains only about 10' copies of a single-copy gene like
157. "Tidiness and adherence to a strict set of protocols can avoid disaster." B. Furrer et
al., Improving PCR Efficiency, 346 NATURE 324 (1990); see also, S. Kwok & R. Higuchi,
Avoiding False Positives With PCR, 339 NATURE 237 (1989).
158. USER GUIDE, supra note 82, at 2-1. Also, as a general rule, it is good practice to
wear lab coats to protect street clothes from splashed chemicals.
159. Id.
160. Id. at 2-3.
161. Id.
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DQa. 162
Thus, nothing should move "upstream" in the flow of analysis.
The laboratory should be organized into three designated work ar-
eas so that the area in which amplified DNA is handled is physi-
cally isolated from the DNA extraction and PCR setup work areas
(e.g., separate rooms). While they may be located in the same
room, the evidence handling and DNA extraction area should be a
separate, distinct work area from the PCR set up area.' 63 Micros-
copy, photography and any other evidence handling activities
should be conducted in the DNA extraction work area.' If the
work area where amplified DNA is handled is a separate but contig-
uous room, the laboratory design should be such that air flows to-
ward the amplified DNA area. Dedicated equipment should be
clearly labelled for use in each specific work area and not be used
elsewhere.
Various researchers concerned with the problems of carryover
contamination and the expenses involved in completely segregated
laboratory designs have developed internal methods within the
PCR reaction tubes to control such contamination.'65 In these
methods, amplified DNA is rendered incapable of re-amplification
in a subsequent test should it contaminate another sample. While
these methods provide additional protection against contamination,
they still must be used in conjunction with good laboratory
technique.
Regardless of the contamination prevention methods used, no
equipment, large or small, expendable or not, should be allowed to
move from one designated section of the lab to another.' 66 The
162. Id. at 2-1.
163. USER GUIDE, supra note 82, at 2-2.
164. For detailed special precaution guidelines regarding this area, see Id. at 2-3 to 2-4.
165. Stephen Isaacs et al., Post-PCR Sterilization: Development and Application to an
HIV-1 Diagnostic Assay; 19 NUCLEIC ACIDS RES. 109 (1991); George D. Cimino et al., Post-
PCR Sterilization: A Method to Control Carryover Contamination for the Polymerase Chain
Reaction, 19 NUCLEIC ACIDS RES. 99 (1991); Chin-Yih Ou et al., Use of UVlrradiation to
Reduce False Positivity in Polymerase Chain Reaction, BIOTECHNIQUES 442 (1991); Yu
Sheng Zhu et al., The Use of Exonuclease III for Polymerase Chain Reaction Sterilization, 19
NUCLEIC ACIDS RES. 2511 (1991); Mary C. Longo, Use of Uracil DNA Glycosylase to Control
Carry-over Contamination in Polymerase Chain Reactions, GENE 125 (1990); Gobinda Sarkar
& Steve Sommer, Shedding Light on PCR Contamination, 7 NATURE 343 (1990); Gobinda
Sarkar & Steve Sommer, More Light on PCR Contamination, 347 NATURE 340 (1990); Y.
Jinno et al., Use of Psoralen as Extinguisher of Contaminated DNA in PCR, 18 NUCLEIC
ACIDs RES. 6739 (1990); and PERKIN-ELMER CETUS, GENEAMP PCR CARRY-OVER PRE-
VENTION KIT, PART No. N808-0068 PRODUCT LITERATURE (undated).
166. For example, the thermal cycler should not be placed in the area in which samples
are prepared.
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work flow should always be directed one way. This represents sig-
nificant protection for the incoming samples as they are processed.
As the concerns are no less acute in the forensic setting than they
are in the medical and diagnostic arena, preventing carry-over con-
tamination by previously amplified samples through sectioning of
the work area, and preventing the upstream movement of samples,
equipment and supplies represents good laboratory technique which
should be appreciated by everyone who works with PCR. Prior to
sending samples to a lab, the attorney would do well to visit the lab
and determine whether these precautions are in place.
ADMISSIBILITY AND OTHER ISSUES INVOLVING DNA ANALYSIS
IN CRIMINAL TRIALS
With the increasing acceptance of DNA tests in courts
throughout the United States, it appears that the admissibility ques-
tions regarding these testing methods will eventually be moot.
However, the battles are not yet over. PCR cases have been held in
Pennsylvania, Kansas, Texas, California, Florida, Virginia, New
York, Colorado, Ohio, and Oregon.' 67 Overall, as of October,
1991, PCR-based DQct typing methods were used in biological evi-
dence analysis in over 250 cases. 1 61 PCR has also been admitted in
Italy. 169 The evidence has been excluded in only a few cases.' 70
However, the skirmishes are not likely to be over permanently until
more appellate level or higher courts have heard PCR cases.
Controversy has long surrounded the admissibility of scientific
techniques, especially in the criminal trial setting. Since the 1923
decision in United States v. Frye,171 new scientific evidence has been
scrutinized by various legal tests throughout the different jurisdic-
tions within the United States.
167. Forensic Science Associates, PCR DNA COURT CASES, HLA DQca FORENSIC
DNA AMPLIFICATION AND TYPING INFORMATIONAL HANDOUT (3/29/91). In one of the
latest cases, People v. Groves, No. 90CA1049, 1992 Colo. App. LEXIS 369 (Colo. Ct. App.
October 8, 1992), the court ruled that the erroneous inclusion of PCR test results related
solely to transactional evidence was harmless error even though the trial court did not con-
duct a preliminary Frye test on the PCR evidence.
168. Edward Blake et al., Polymerase Chain Reaction (PCR) Amplification and Human
Leukocyte Antigen (HLA)-DQcL Oligonucleotide Typing on Biological Evidence Samples:
Casework Experience, 37 J. FORENSIC SCI. 700 (1992).
169. See Bruno Dallapiccola et al., PCR DNA Typing for Forensics, 354 NATURE 179
(1991). A subsequent paper challenged the methods used in the PCR tests admitted in the
case referred to in the Dallapiccola paper. Angelo Fiori & Vincenzo L. Pascali, Forensic Use
of PCR in Italy, 356 NATURE 471 (1992).
170. People v. Martinez, No. C 82183 (Los Angeles Super. Ct. 1989); and People v.
Mack, No. 861116 (Sacramento Super. Ct. 1990).
171. 293 F. 1013 (D.C. Cir. 1923).
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Just when a scientific principle or discovery crosses the line be-
tween the experimental and demonstrable stages is difficult to de-
fine. Somewhere in this twilight zone the evidential force of the
principle must be recognized, and while courts will go a long way
in admitting expert testimony deduced from a well-recognized
scientific principle or discovery, the thing from which the deduc-
tion is made must be sufficiently established to have gained gen-
eral acceptance in the particular field in which it belongs.
1 72
As with many other scientific methods, there has been a long
history of attacks on the scientific analysis of blood and other body
fluids. As recently as 1988, there were court challenges to the relia-
bility of ABO typing of blood and other stain evidence.173
In the case of DNA analyses, most of the arguments go back to
the traditional claim that forensic evidence is different from clinical
samples obtained in the "pristine" medical setting. These same ar-
guments occurred in the 1970s-1980s regarding electrophoretic typ-
ing of proteins such as PGM in bloodstains and other bodily fluid
evidence.174 It was not until the relatively recent case of People v.
Reilly,' that the electrophoresis debate was settled for good in
California.
The DNA debate is still very active, as evidenced by the ap-
proximately twenty appellate and state supreme court decisions dis-
cussing the admissibility of DNA typing. 176
172. Id. at 1014.
173. C. Holden, Science in Court, 243 Scl. 1658 (1987); and W.F. Rylaarasdam, Farewell
to Hired Guns, Judges Should Pick Their Own Experts to Testify on Technical Issues, S.F.
DAILY J., August 26, 1992, at 4. See also, Sheila Jasanoff, Science on the Witness Stand,
ISSUES Sci. TECHN., Fall 1989, at 80.
174. David D. Dixon, The Admissibility of Electrophoretic Methods of Genetic Marker
Bloodstain Typing Under the Frye Standard, 11 OKLA. CITY U. L. REv. 773 (1986); R.E.
GAENSSLEN, SOURCEBOOK IN FORENSIC SEROLOGY, IMMUNOLOGY, AND BIOCHEMISTRY
(1983); R.E. GAENSSLEN (ED.), SOURCEBOOK IN FORENSIC SEROLOGY, IMMUNOLOGY, AND
BIOCHEMISTRY UNIT IX: TRANSLATIONS OF SELECTED CONTRIBUTIONS THE ORIGINAL
LITERATURE OF MEDICOLEGAL EXAMINATIONS OF BLOOD AND BODY FLUIDS (1983); Jo-
seph R. Melvin et al., Paternity Testing, in 2 FORENSIC SCIENCE HANDBOOK 273 (Richard
Saferstein ed., 1988); F. Samuel Baechtel, The Identification and Individualization of Semen
Stains, in 2 FORENSIC SCIENCE HANDBOOK 348 (Richard Saferstein ed., 1988); Henry C.
Lee, Identification and Grouping of Bloodstains, in FORENSIC SCIENCE HANDBOOK 267
(Richard Saferstein ed., 1988); and Sensabaugh, supra note 114.
175. 242 Cal. Rptr. 496 (Cal. Ct. App. 1987).
176. George W. Clarke, supra note 76, at 5,7. For a sample of a Kelly-Frye motion in
opposition to the introduction of RFLP evidence, see Walter F. Krstulja, Sample Kelly-Frye
Motion Opposing the Introduction of DNA (RFLP) Evidence, 5 CAL. DEFENDER, No. 1, 1992,
at 40.
BIOTECHNOLOGY / LIFE SCIENCES LAW
1993] POL YMER4SE CHAIN REACTION 327
A. California's Kelly-Frye Test
In assessing whether scientific evidence should be admitted,
California uses the test set forth in People v. Kelly, 17 7 a case which
expands the basic legal prerequisites for admissibility previously es-
tablished by Frye.
[The] admissibility of expert testimony based upon the applica-
tion of a new scientific technique traditionally involves a two-step
process: (1) the reliability of the method must be established, usu-
ally by expert testimony, and (2) the witness furnishing such tes-
timony must be properly qualified as an expert to give an opinion
on the subject. Additionally, the proponent of the evidence must
demonstrate that correct scientific procedures were done in the
particular case.
1 7 1
The function of the Kelly-Frye rule is to safeguard against the
presentation of either unfounded or prematurely developed scien-
tific methods, or unfounded evidence to juries.'7 9 The reasoning is
that "[flay jurors tend to give considerable weight to 'scientific' evi-
dence when presented by 'experts' with impressive credentials."' 8 °
Kelly-Frye hearings are preliminary hearings in which the
judge determines whether or not to permit particular scientific evi-
dence to be presented to the jury during trial. In a typical Kelly-
Frye hearing, both the proponent and the opponent of the scientific
technique bring in a parade of scientific experts and present their
best arguments for or against the admissibility of the particular sci-
entific evidence involved. Thus, the proponent's witnesses will tes-
tify to the usefulness, reliability and overwhelming acceptance of
the technology within the appropriate scientific community, while
the opponent's witnesses will testify to its absolute worthlessness.
It is important to remember that the issue to be decided in a
Kelly-Frye hearing is the admissibility, not the weight of the evi-
dence.' t In California, the decisions in People v. Smith 182 and Peo-
ple v. Farmer183 have more clearly defined the narrow scope of the
legal admissibility inquiry. As stated in Smith, "the Frye test dic-
tates that criticism of the specific methodology employed goes to the
177. 549 P.2d 1240 (Cal. 1976).
178. Id. at 1244 (citations omitted)(emphasis in original); See also, People v. Shirley, 641
P.2d 775, 795 (Cal. 1982); and People v. Brown, 709 P.2d 440, 447-448 (Cal. 1985).
179. People's Points and Authorities Defining the Parameters of the Kelly-Frye Hearing
at 2, People v. Lewis, No. C-27037 (San Mateo Super. Ct. Oct. 15, 1991).
180. Kelly, 549 P.2d at 1245 (1976).
181. People v. Marx, 126 Cal. Rptr. 350, 356 (Cal. Ct. App. 1975).
182. 263 Cal. Rptr. 678 (Cal. Ct. App. 1989).
183. 765 P.2d 940 (Cal. 1989).
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credibility of the testimony, not admissibility."'' 84
As there is no requirement that the court must understand the
technology in question, the judge's role in Kelly-Frye is relatively
limited. In a case involving hypnosis, the California Supreme Court
stated, "our duty is not to decide whether hypnotically induced re-
call of witnesses is reliable as a matter of 'scientific fact,' but simply
whether it is generally accepted as such by the relevant scientific
community."' 5 Nonetheless, because most people probably prefer
to know what is going on around them, it would be advisable to
present the evidence in such a way that the judge is able to grasp the
concepts and understand the technology and vocabulary, at least on
a rudimentary level.
Also importantly, there is no requirement for absolute unanim-
ity of views within the scientific community prior to the determina-
tion that a new scientific method is reliable.
The Frye test does not demand the impossible-proof of an abso-
lute unanimity of views in the scientific community before a new
technique will be deemed reliable; any such unanimity would be
highly unusual ..... Rather, the test is met if the use of the
technique is supported by a clear majority of the members of that
community. 1
86
Kelly/Frye does not demand judicial absorption of all the rele-
vant literature, nor does it require a decision once and for all
whether a particular kind of scientific evidence is reliable. The
court need only conduct a 'fair overview' of the subject, sufficient
to disclose whether 'scientists significant either in number or ex-
pertise publicly oppose [a technique] as unreliable' [citation].18 7
Quite simply, the only determination to be made during a
Kelly-Frye hearing is whether or not the scientific technology is gen-
erally regarded as reliable within the relevant scientific community.
This itself has fueled some debate concerning the scope of the rele-
vant scientific community and the degree of acceptance which can
be considered "general." In terms of the "relevant scientific com-
munity," it appears that most courts are willing to adopt a broad
view with regard to PCR testing. 88
184. Smith, 263 Cal. Rptr. at 682-83 n.4 (citing State v. Adams, 418 N.W.2d 618 (S.D.
1988))(emphasis in original).
185. People v. Shirley, 641 P.2d 775, 797 (Cal. 1982).
186. People v. Reilly, 242 Cal. Rptr. 496, 509 (Cal. Ct. App. 1987)(quoting People v.
Guerra, 690 P.2d 635, 656 (Cal. 1984))(emphasis added).
187. Reilly, 242 Cal. Rptr. at 509 (quoting People v. Brown, 709 P.2d 440, 450 (Cal.
1985)).
188. The judges in some cases have indicated that the relevant scientific community is
[Vol. 20
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At the hearing, the proponent of the evidence has the burden
of bringing in suitable expert witnesses willing to testify to the ac-
ceptance of the technology in the scientific community. In order to
testify, the witness(es) must be properly qualified by the court as
expert(s) in the field. With the help of the attorney, the proponent's
expert witnesses must establish, by a preponderance of the evidence,
that the method is reliable and accepted within the scientific com-
munity. Thus, the proponent of the evidence has the burden of
making the necessary showing of compliance with Frye, (i.e., of
demonstrating by means of qualified and disinterested experts that
the new technique is generally accepted as reliable in the relevant
scientific community).18 9
In addition to the reliability of the evidence and the qualifica-
tion requirements for expert witnesses, there is a "correct proce-
dure" prong in the Kelly-Frye standard."9 Thus, it must be
determined that the technique was performed reliably in the case at
issue, before the evidence may be presented to the trier of fact. 9 ' If
the test procedure was not reliably performed, then the evidence
should not be admitted. This requirement highlights the necessity
for the attorneys to be familiar with the lab and personnel who con-
ducted the DNA analysis.
In addition to correct laboratory procedures, attorneys must be
familiar with the statistical methods used to calculate the probabili-
ties that the person on trial is the one responsible for the crime.
This is largely due to the large amount of discussion regarding the
admissibility status of statistical evidence.
For example, in People v. Collins,192 the prosecution's use of
statistical approximation was criticized on two levels: (1) the prose-
cution failed to introduce proof of the probability of individual
events; and (2) the prosecution failed to present any proof of the
mutual independence of those individual frequencies. However,
this decision does not stand for the proposition that in the face of
not limited to forensics, but encompasses the entire scientific community which uses PCR.
People v. Moffett, No. 103094 (San Diego County Super. Ct. May, 1991); People v.
Quintanilla, No. C-23691 (San Mateo County Super. Ct. Aug. 16, 1991). However, there
have been other Kelly-Frye hearings in which the PCR evidence was excluded as not being
accepted in the relevant scientific community. People v. Mack, No. 86116 (Sacramento
Super. Ct. Sept. 1990).
189. Shirley, 641 P.2d at 796. See also, Brown, 709 P.2d at 447-448, and Kelly, 549 P.2d
at 1244.
190. Kelly, 549 P.2d at 1244.
191. Reilly, 242 Cal. Rptr. at 513-14; People v. Dellinger, 209 Cal. Rptr. 503, 509-10
(Cal. Ct. App. 1984).
192. 438 P.2d 33 (Cal. 1968).
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disagreement regarding the quality of proof on either of these
points, a trial judge has the authority to preclude their presentation
to the jury.
In People v. Yorba, 93 the court followed well established Cali-
fornia precedent in finding that statistical estimations based on bio-
logical evidence is a weight and not an admissibility issue,
particularly when the estimations are based on the application of
long-standing scientific principles.' 94 It would certainly seem that
the Mendelian inheritance exhibited by HLA DQa would fall into
the category of "long-standing scientific principle." Even test pro-
cedures which have the potential for statistical estimation, but
which yield only equivocal results, have been deemed admissible.'9 5
The simple fact that a defendant is not excluded by test results has
been found relevant for the jury to learn.196 Thus, the population
genetics and frequencies associated with PCR and RFLP should go
to the weight of the evidence, not its admissibility.
Nonetheless, many commentators have argued that DNA evi-
dence should be regarded as unreliable unless and until detailed evi-
dence on population structures is available.' 97  However,
probabilities have been used for many years. Thus, there is no rea-
son to summarily disregard them simply because they are applied to
DNA analyses. A "statement of a probability is, by its nature, a
statement of partial knowledge, so it is paradoxical to imply that in
principle we cannot calculate the probability of an event without
further empirical knowledge."' 98 Much is already known about the
population substructures for various loci, including DQa. Also,
when is enough, enough? When would the opponents to the use of
DNA in court cases be satisfied that the population studies were
sufficient and the statistical methods appropriate?' 99
193. 257 Cal. Rptr. 641 (Cal. Ct. App. 1989).
194. Id. at 645-646.
195. In People v. Cooper, 809 P.2d 865 (Cal. 1991), two cigarette butts found at a crime
scene were analyzed in an attempt to determine whether the defendant might have smoked
them.
This endeavor would have been much easier if PCR had been used to analyze saliva on
the cigarette butts. M.N. Hochmeister et al., PCR-Based Typing of DNA Extracted From
Cigarette Butts, 104 INT'L J. L. MED. 229 (1991).
196. Cooper, 809 P.2d at 888.
197. See, e.g., R.C. Lewontin & D.L. Hartd, Population Genetics in Forensic DNA Typing,
254 Sci. 1745 (1991).
198. John Brookfield, Law and Probabilities, 355 NATURE 207 (1992).
199. See D.A. Stoney, Reporting of Highly Individual Genetic Typing Results: A Practical
Approach, 37 3. FORENSIC Sct. 373 (1992) for a detailed discussion of the interpretation of
serologic typing data, population genetics, statistics, and the peculiarities of DNA testing in
the forensic arena.
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B. The Bar's Response to DNA Testing
It is somewhat surprising that defense associations are so ada-
mantly opposed to DNA tests when they can absolutely exclude a
person on trial from being the perpetrator of the crime.2" A good
example is the first suspect arrested in the Quintanilla case, but ex-
onerated based on PCR typing.2"1 Of 250 PCR cases, 70% of the
PCR analyses were requested by the prosecution and 30% by the
defense.20 2 In 198 cases, 35% resulted in the exclusion of the sus-
pect and 65% in inclusion; the same percentage of inclusions was
obtained for cases done at the request of the prosecution as those
done at the request of the defense.
20 3
The power of exclusion represents much of the benefit pro-
vided by PCR. If a suspect is excluded, that's it. If a suspect is
included, that's all it means. Other evidence will be needed in order
to conclusively establish that the person is indeed the true culprit.
The defense should consider the possibility that without DNA evi-
dence, an innocent person may be convicted.
The high rate of exclusions (including inconclusive results)
may be due to various factors, including the irrelevance of the evi-
dence to the crime, or, in sexual assault cases, the failure of the
rapist to ejaculate, or recent sexual activity of the victim. 2° 4 Until
additional systems are developed which will enhance the discrimi-
nation power of the tests, other testing methods and/or evidence
will be required in order to result in conviction. Because DNA test-
ing is so useful to the innocent defendant, one would think that
defense attorneys would be more circumspect in their evaluation of
the methods. Post-conviction reversals due to PCR test results have
been obtained in at least five cases.2 °5 It is rather hypocritical to
oppose the admission of DNA tests when the prosecution is the pro-
ponent of the evidence, but vigorously work for its admission when
200. Edward T. Blake et al., Polymerase Chain Reaction (PCR) Amplification and
Human Leukocyte Antigen (HLA)-DQa Oligonucleotide Typing on Biological Evidence Sam-
ples: Casework Experience, 37 J. FORENSIC Sci. 700 (1992). See also, Sherman, supra note 1.
201. See supra note 8.
202. Blake et al., supra note 200, at 721.
203. Id.
204. Id.
205. Telephone Interview with Edward Blake, Forensic Science Associates (Nov. 5
1992). These defendants include Gary Dotson (Illinois), Woodall (West Virginia), Joe Jones
(Kansas), Steve Linscott (the "dream slayer") (Illinois), and Cary Cotler (New York).
In the Woodall case, the defendant recently settled with West Virginia for $1 million, the
maximum sum which he could have received had there been a trial. This settlement was
apparently arranged by the state in order to avoid revealing the full extent of prosecutorial
misconduct which occurred during Mr. Woodall's trial. Id.
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the defense is the proponent."° Indeed, this appears to be the case
in an on-going attempt by Peter Neufeld, a prominent New York
attorney, to reverse the New York conviction of a man serving time
for rape.20 7 Mr. Neufeld has been against the admission of DNA
results. 20 ' However, as it now appears that PCR will be able to
exonerate a client, he has become a proponent of the test.
To date, there have been no cases in which an innocent defend-
ant has been convicted solely on the basis of DNA analysis. Such a
circumstance is likely to never occur. Indeed, in a recent Connecti-
cut case, the jury completely disregarded the exonerating DNA evi-
dence.2 1 "At times, testing fails to produce results, but it has never
created false positives.
' 21 0
One author argues that the rights involved in criminal trials
are so overwhelmingly important that such a new technology
should not be used.21 However, these arguments are greatly dimin-
ished by the fact that PCR is used in many life and death settings,
many of which involve no "suspect. ' ' 2 t 2 For example, PCR is used
in genetic counselling213 and may contribute to the decision of a
couple to terminate a pregnancy should the fetus be severely de-
206. Judge Mudd noted that in different cases, both the prosecution and the defense have
opposed PCR. Reporter's transcript, at 1010, People v. Moffett, No. 103094 (San Diego
Super. Ct. 1991). Judge Mudd views this as indication that PCR is ready for the courtroom; it
isn't any different from any other evidence-"if it's for you, you're willing to support it; if it's
agin you, you're willing to challenge it." Id. at 1010. He found it an interesting and telling
factor that in a number of cases, the defense had found it necessary to support PCR. Id. at
1010-1011.
207. As relayed by Edward Blake, supra note 205. See also, Sherman, supra note 1.
208. See Peter J. Neufeld and Nelville Colman, When Science takes the Witness Stand,
ScI. AM. May, 1990, at 46.
209. In March 1990, a six-person jury ignored the exculpating DNA evidence analyzed
for the defense by the FBI laboratory and convicted Ricky Hammond of a 1987 kidnapping
and rape. See Connecticut's Doubtful Claim to Fame: DNA Results Rejected by Jury, Sci.
SLEUTHING NEWSL., Winter 1990, at 6; Jack Ewing, Connecticut Jury Disregards DNA Test,
NAT'L L.J., Apr. 23, 1990, at 9.
In Moffett, Judge Mudd noted that, "I don't think trial lawyers give jurors enough credit
for being intelligent, because my personal experience with RFLP was that in jury question-
naires they were able to put that particular evidence in the context of the entire trial and give
it the weight to which they felt it to be entitled." Kelly/Frye Hearing Transcript at 1014,
People v. Moffett, CR-103094 (San Diego Super. Ct. 1991).
210. L. Koblinsky, Recovery and Stability of DNA in Samples of Forensic Science Signifi-
cance, 4 FORENSIC Sci REV. 67, 79 (1992).
211. See Hoeffel, supra note 1, at 495.
212. The fact that life and death decisions are being made daily based on PCR made
such a significant impression on Judge Mudd, that he commented on Judge Tochterman's
finding that in criminal law, the standard must go beyond that acceptable in the medical,
scientific and research communities. Reporter's Transcript at 1007, People v. Moffett, No.
103094 (San Diego Super. Ct. 1991).
213. This also includes determining the sex of a fetus. Michal Witt & Robert P. Erick-
[Vol. 20
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formed or genetically "defective." The couple is able to make the
tough, yet informed decision concerning whether to terminate the
pregnancy or be prepared for a child with special requirements and
needs should they choose to continue the pregnancy. The use of
PCR in the genetic assessment of fetuses is most certainly of life and
death importance and magnitude.
The use of PCR in genetic counselling may impact the choice
of prospective parents to even conceive."' If they know that they
are extremely likely to have an infant with serious mental and/or
physical impairments, a couple may be more likely to adopt a
healthy child rather than take the risk of having their own.
With the overwhelming acceptance of PCR in a wide variety of
scientific disciplines and its increasing court acceptance, admissibil-
ity should soon be an issue of the past. The fight can then be shifted
to the weight of the evidence, as it is with most other types of physi-
cal evidence presented at trial. Whether the laboratory is reputable,
conducts "good" science, and follows established protocols will be-
come the primary focus. If the laboratories conducting the tests
meet the strictest of controls, then the evidence should be allowed
to speak for itself in either implicating or exonerating the involved
person. Expert witnesses should help, rather than hinder the court
in understanding the technologies and their limitations.
C. Expert Witnesses
In view of its widespread use and overwhelming adoption by a
great number of scientists working in numerous disciplines world-
wide, it is very difficult to imagine that a molecular biologist with
any practical experience would agree to testify that PCR is unrelia-
ble and not useful in the appropriate scientific community.2"5 Per-
haps the availability of generous expert witness fees and the
perceived ego-boost associated with legal recognition as an "expert"
has led some scientists, traditionally short of funding for their re-
search projects to make statements in court which are not only mis-
leading, but are actually false.
Great care must be used in the selection of expert witnesses.
son, A Rapid Method for Detection of Y-Chromosomal DNA From Dried Blood Specimens by
the Polymerase Chain Reaction, 82 HUM. GENETICS 271 (1989).
214. See Scott C. Kogan et al., An Improved Method for Prenatal Diagnosis of Genetic
Diseases By Analysis of Amplified DNA Sequences, 317 NEw ENG. J. MED. 985 (1987).
215. It is even included as an important part of the most recent genetics textbooks such
as SINGER & BERG, supra note 9, at 420-25.
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One author suggests that qualified experts should exhibit the
following:
(I) undergraduate and graduate degrees in the relevant field of
expertise, (2) specialized training in the subject area as it relates
to forensics, (3) some training in forensics, (4) those professional
licenses or certifications universally required by recognized pro-
fessional groups in the expert's discipline, (5) evidence of experi-
mentation, teaching, publication within the specialty area, or
some combination of these, (6) prior disciplinary evidence that is
direct and relevant to the issues or issues being considered. Also
desirable would be (1) postgraduate (or postdoctoral) training,
(2) publications which appear in (reviewed) sceintific journals,
(3) the development of scientifically acceptable tests or proce-
dures, (4) association with, and leadership in, appropriate scien-
tific societies, and (5) experiences as an expert witness.2 16
Not only must expert witnesses in DNA trials be well-in-
formed and current on the most up-to-date technologies, they
should also have practical experience in the methods used to ana-
lyze DNA. Those "experts" whose only experience has been gained
tangentially or solely through the literature should be viewed with
great skepticism.
The Court in People v. Brown,217 included an additional ca-
veat-that the witness "must also be 'impartial,' that is, not so per-
sonally invested in establishing the acceptance of the technique that
he might not be objective about disagreements within the relevant
scientific community."2 1 Common warning signs that an expert
witness is biased include, that he/she (1) is exclusively or almost
exclusively, a witness for one side (prosecution or defense), (2)
makes statements that he/she "could not be wrong," (3) does not
describe the evaluation procedures used in his/her laboratory
("they are classified" or "too complex to understand"), (4) does not
bring data, materials or the relevant examination results to the
courtroom, and/or (5) makes unwarranted (oftentimes vague) per-
sonal attacks on opposing witnesses.2 19
Financial ties and potential biases of any expert witnesses
should be disclosed in the trial before the jury, not at the admissibil-
ity preliminary hearing stage. The court in New Jersey v. Wil-
216. H. Hollien, Expert Witness: Ethics and Responsibilities, 35 J. FORENSIC SCI. 1414,
1417 (1990).
217. People v. Brown, 709 P.2d 440 (Cal. 1985).
218. Id. at 448.
219. Hollien, supra note 216, at 1416.
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liams22° stated that, "evidence of the financial rewards that a
witness or a corporation with whom he is associated will gain from
the use of the new scientific technique will surely be presented to the
jury which can determine what weight, if any, to give to the testi-
mony of each expert."22 ' As the State in the same case contended,
"simply because learned experts earn a living with their expertise
should not prohibit the admissibility of their opinions. ' 222 Imparti-
ality concerns have lead to many discussions regarding the testi-
mony of scientists who are very involved in the development and
use of new technology, usually within the industry setting. How-
ever, there are those within the academic research community who
could be viewed as biased one way or another regarding the technol-
ogy. 223 Perhaps the ties of all experts should be disclosed to the
jury. It is possible that jurors would be shocked at the very gener-
ous fees collected by expert witnesses, some of whom seem to be on
the "circuit" so to speak, ready and willing to testify for a fee.
One product of the litigation involving DNA typing has been
the development of a "cottage industry" or "welfare state" of de-
fense experts (including some attorneys) who travel around the
country to testify against the admissibility of DNA testing. For
many of these experts, most of their yearly income is derived from
in-court testimony. 224  Various authors have expressed concern
about the ethics or advocacy displayed by some experts. 2  Per-
haps, as some authors have suggested, the court should appoint and
pay for expert witnesses, as courts do in other countries.226
Regardless of their source of payment, it is possible that per-
sonal vendettas and a desire to continue a controversy long after it
has been resolved (quite possibly in order to continue collecting ex-
pert witness fees) will continue to greatly disserve the legal and sci-
entific communities and justice system. Instead of directly
addressing the issues in the case, the attorneys, judges and juries are
forced to witness the in-fighting and personality conflicts between
scientists who sometimes have egos as large as their counterparts in
220. No. 1991 WL 276327, at *7 (N.J. Super. L. Aug. 5, 1991).
221. Id.
222. Id.
223. Perhaps this is fostered by the highly competitive "publish or perish" mentality
within academia. It is undoubtedly a resume enhancer if a scientist can include testifying in
court regarding science.
224. Clarke, supra note 76, at 27-28.
225. See Hollien, supra note 216, at 1415 for a list of references which express this view.
226. Holden, supra note 173; and Rylaarsdam, supra note 173.
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the legal profession. 2"
Some scientists, by succumbing to the seductive aspects of tes-
tifying in court, have done much to discredit themselves in the eyes
of the scientific community at. large. Many of these people are sim-
ply ill-informed. Although they may not intentionally misrepresent
the technology, many are unfamiliar with courtroom procedures,
cross-examination, and/or forensics and are made to look like fools
through their own testimony.22
Expert witnesses must be familiar with the techniques used in
the particular case in which they are testifying. Many principal re-
searchers within the academic community are professors who do
very little actual laboratory research; they are often forced to leave
the "bench work" to their post-doctoral fellows, graduate students,
undergraduates and technicians. The reality of the academic situa-
tion is that professors must devote time to acquiring and adminis-
tering grants, serving on school committees, advising graduate,
undergraduate and potential students, preparing and presenting pa-
pers at professional meetings and for publication, participating in
school events, as well as teach. It is easy to see why many academ-
ics simply do not have the time to conduct much hands-on research
themselves. However, it is only through the practical application of
these techniques that a scientist will become sufficiently familiar
with the methods to testify fairly and accurately.
One embarrassing example is the testimony of Dr. Mary-Claire
King, an expert witness who testified in the People v. Mack229 and
People v. Mello2 a° Kelly-Frye hearings regarding the AmpliTypet
DQct test kit. In the Mack hearing, Dr. King stated that she was
not aware of the results of the test kit blind trials conducted by the
California Association of Crime Laboratory Directors and that
these results had not been published.23 However, the results of the
first round were published in 1988. She also admitted that she was
in error when she stated in the Mello hearing that Alan Wilson de-
veloped PCR technology. 23 2 Furthermore, she admitted that she
had not even read the protocol manual used in conjunction with the
227. See Reporter's Transcript, at 53-54, People v. Williams, No. 110047 (San Francisco
Super. Ct. 1983); People v. Brown, 709 P.2d 440 (Cal. 1985).
228. See, e.g., Reporter's Transcript, at 2248-2252, People v. Mack, No. 86116 (Sac.
Super. Ct. 1990) [hereinafter, Mack Transcripts]. See also, Hollien, supra note 216 at 1416-
1417.
229. Mack Transcripts, supra note 228.
230. Reporter's Transcript at 3480, People v. Mello, No. 27819 (Riverside Super. Ct.
1989) (hereinafter Mello Transcripts].
231. Mack Transcripts, supra note 228, at 2244-2247.
232. Mello Transcripts, supra note 230, at 2248-2250.
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AmpliTypeT DQa test kit ("AmpliTypeO User Guide")2 33,
although she testified that she had used the kit. She also testified
that she learned about PCR from a paper on the extinct quagga;
234
the "quagga paper" did not even involve the use of PCR.
235
This type of testimony is a shining example of why the aca-
demic community is not necessarily the best source for expert wit-
nesses, contrary to the admonitions of Thompson and Ford, two
commentators on the use of DNA testing who stated that "[t]o find
experts who are "disinterested and impartial," courts will need to
look to the academic community., 23 6 It would seem highly prob-
able that an expert in PCR and molecular biology would at least
know who originally developed PCR technology. An indignant
contingent of scientists very knowledgeable in PCR and molecular
biology were sufficiently outraged by the Mello admissibility hear-
ings to publish a response to the inaccurate interpretation of the
DQcL evidence. 237
Justification for the use of academicians as expert witnesses has
also included such statements as "[m]ost studies evaluating DNA
typing are published by employees of these companies, or university
researchers who have a financial relationship with these compa-
nies. ' 23" However, with the literally thousands of articles on PCR
and DNA typing published in the scientific literature, this statement
is very difficult to defend.
It is also important for the legal community to realize that one
of the major goals of the scientific literature is to present materials,
methods and results of particular experiments and investigations,
especially in peer-reviewed journals.239 Scientific articles must be
published in a manner such that the experiments may be repeated
by others. Results from these repeated experiments are published
which either confirm or dispute the procedures and/or results of the
original experimenters. It is through this continual interaction be-
tween researchers, that scientific principles develop and gain
acceptance.
233. Id. at 2234-2236, 2281-2282.
234. Id. at 3480.
235. Higuchi et al., supra note 45.
236. DNA Typing, supra note 133, at 59. See also, Ricardo Fontg, supra note 29, at 530.
237. Henry A. Erlich et al., Reliability of the HLA-DQa PCR-based Oligonucleotide Typ-
ing System, 35 J. FORENSIC ScI. 1017 (1990).
238. DNA Typing, supra note 133, at 59.
239. Given the large number of comments and articles in the legal literature which con-
tain erroneous material regarding DNA testing and methods, perhaps the legal profession
should consider adopting a peer-review process for law reviews.
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It is very unlikely that there is a paper published in the scien-
tific literature which refutes the statements and results of the
Higuchi et al. paper,2" called into question by Thompson and
Ford24 ' because two of the authors, Higuchi and Erlich are Cetus
researchers. Also, not mentioned in the Thompson and Ford arti-
cle, the other two researchers involved, Celia von Beroldingen and
George Sensabaugh, were associated with the University of Califor-
nia, not Cetus. Regardless of their affiliation, just because a scien-
tist works for a particular company does not mean that he or she
will be unethical on the witness stand or in the scientific press. To
do so is professional suicide. Such persons are eventually discov-
ered and made to pay the price, a good example being the recent
investigations into Gallo's laboratories regarding the discovery of
HIV.242 Whether a scientist works in the biotechnology industry
or at an university, it does not necessarily mean that they leave their
ethics at home when they come to testify in court.
D. The Impact of People v. Castro243
Easily the most discussed DNA case, Castro has become the
signal case used by those opposed to the use of DNA evidence, as it
represents the first successful challenge to DNA typing evidence.
However, despite the outburst of criticism and dire predictions in
the legal and lay literature, Castro has not been repeated.
Although others may disagree, and although the case did not
even involve a "crime lab" per se, the fiasco of Castro has had both
positive and negative effects on forensic science. Notwithstanding
the outcry regarding the case, the impact of Castro in New York
courts appears to be minimal, as demonstrated by subsequent
cases.2 In many respects, the entire Castro incident was really
nothing more than a tempest in a teapot.
What has been lost in the excitement generated by the case is the
fact that the opinion is merely the trial court's assessment of a
legal issue which the prosecution had rendered moot by conced-
ing in its brief that the evidence of a match in DNA patterns was
inadmissible. Mr. Castro later pled guilty, thus the soundness of
the trial court's legal opinion will never be reviewed on
240. Higuchi et al., supra note 126.
241. See DNA Typing, supra note 133, at 59.
242. Malcolm Gladwell, At NIH, An Unprecedented Ethics Investigation: New Questions
Involving Scientist Robert Gallo and Discovery of HIV Being Probed, WASH. POST, Aug. 17,
1990, at AS.
243. 545 N.Y.S.2d 985 (N.Y. Sup. Ct. 1989).
244. See, e.g., People v. Shi Fu Huang, N.Y.S.2d 920 (N.Y. Co. Ct. 1989).
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appeal.245
On the positive side, Castro put the laboratories conducting
DNA testing on notice that the judicial system is not willing to ac-
cept evidence based on sloppy and questionable test methods.
While the Castro court declined to state that evidence gained
through proper procedures would be inadmissible, it did exclude the
evidence in this case because Lifecodes, the lab hired to conduct the
DNA (RFLP) tests, did not even follow its own guidelines.24 6 Cas-
tro also points out some areas in which attorneys can deal with this
type of data and possibly find sources of error.
247
On the negative side, Castro provided much fodder for the
opponents of DNA testing who sensationalize the issues and claim
to consider DNA testing as either unreliable, unverifiable, too inva-
sive of privacy and/or simply too difficult and complex to
understand.24 8
One bit of science that the Castro court seized upon was the
"mixing" experiment. While in its judicial activism mode, the court
made several suggestions to the scientific community regarding cer-
tain procedures, one of which was the mixing experiment proposed
by Lander, a prominent population geneticist. Lander insisted that
if one mixed a known sample with an unknown sample which was
thought to be from the same source prior to performing RFLP, then
if the bands moved to the same place on the gel, they could be from
the same source.249 While this type of solution to bandshifting in
RFLP may be appropriate for paternity cases, it has been shown to
be unworkable in forensic cases.210 Unfortunately, the Castro court
gave great weight to this advice.
Other aspects deserving of mention include: (1) all of the evi-
dence was consumed in the testing; (2) the trial court ruled that the
forensic DNA identification test met the Frye standard; (3) the
court ruled that population frequency data should be related to the
245. Rockne Harmon, DNA Fingerprinting Critics Titillate Rather Than Inform, L.A.
DAILY J., March 14, 1990, at 6.
246. Castro, 545 N.Y.S.2d at 997.
247. Roger Parloff, How Barry Scheck and Peter Neufeld Tripped Up the DNA Experts,
AM. L., Dec. 1989, at 50.
248. See Petrovich, supra note 133; Pearsall, supra note 133; Lander, supra note 112;
Hoeffel, supra note 1. These are but a few of the multitude of review articles covering Castro
and the problems encountered.
249. Lander, supra note 112.
250. McNally et al., Increased Migration Rate Observed in DNA From Evidentiary Mate-
rial Precludes the Use of Sample Mixing to Resolve Forensic Cases of Identity, I APPLIED
THEORETICAL ELECTROPHORESIS 267 (1990), discussed in Amicus Curiae's Brief at 29, Peo-
ple v. Barney, No. A048789 (Cal. Ct. App. I Dist. 1991).
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weight of the evidence, not the admissibility; (4) the court rendered
an opinion in spite of the prosecution's concession that the match
between the samples was unreliable and therefore inadmissible; (5)
the results conceded by the prosecution to have been unreliable and
deemed by the court to have been deficient were later demonstrated
to have given the correct result; when Mr. Castro later pled guilty,
he admitted that the blood on his watch spattered there when he
stabbed the victim; (6) private labs such as Cellmark and Lifecodes
are not crime labs per se, and their analysts are molecular biologists
who generally have no appreciation for the characteristics of foren-
sic samples, nor the considerations involved in testing them; and (7)
because there was a guilty plea, the legal soundness of the trial
court's decision will never be examined on appeal. One develop-
ment, due largely to the debacle of Castro, has been the call for state
and/or federal regulations pertaining to the use of DNA evidence.
PROPOSED REGULATIONS
A. History
In the forensic science world, regulations have long been con-
troversial. Unlike clinical laboratories,25 ' crime laboratories are not
subject to regulation. 25 2 Many criminalists have long felt that there
is no need for outside regulation because, in contrast to the clinical
setting, crime laboratories are subject to rigorous review by courts
and juries.253 While this is true, there has been much concern
voiced in the legal and forensic literature regarding the need for
regulation through some other mechanism. 25 4
A recent report by the Committee on DNA Technology in Fo-
rensic Science, as approved by the National Research Council
251. Clinical laboratories are subject to various regulatory programs and agencies, in-
cluding the Health Care Financing Administration (HCFA) of the U.S. Department of
Health and Human Services and the Joint Commission for the Accreditation of Hospitals and
Health Care Organizations (JCAHO). The most recent major legislation concerning clinical
laboratories was the Clinical Laboratory Improvement Amendments of 1988 (CLIA), Pub.
L. No. 100-578, 102 Stat. 2901 (1988) which addresses the need for uniform federal profi-
ciency testing standards. See also, 55 Fed. Reg. 20,896 (1990); 42 C.F.R. Parts 405, 416, 440,
482, 483, 488 and 493.
252. The exception to this is blood alcohol analysis, which in California is administered
by the Department of Health Services under Cal. Admin. Code Title 17.
253. Interview with Gordon Deeg, Senior Criminalist, San Mateo Police Department, in
San Mateo, CA (Oct. 5 1992).
254. David Helvarg, Crime Labs Under the Microscope, CAL. L., Dec. 1991, at 43; Simon
J. Young, DNA Evidence-Beyond a Reasonable Doubt?, 1991 CRIM. L.R., 264. See also,
Mark Thompson, DNA's Troubled Debut, CAL. L., June 1988, at 36.
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(NRC),2" and the FBI's Response to that Report stress the neces-
sity for national standards.2 56 The call for standards is primarily
related to a desire to instill public confidence in the accuracy and
reliability of DNA test results. 2-7 Contrary to the disinformation
published in the lay press upon the release of the Report by the
Committee on DNA Technology in Forensic Science,258 the Com-
mittee did not conclude that "courts should cease to admit DNA
evidence until laboratory standards have been tightened and the
technique has been established on a stronger scientific basis.
259
The Committee does however emphasize the need for a high level of
quality control in the collection, analysis and interpretation of data.
It also recommends standardization of laboratory procedures, and
establishment of a mandatory accreditation program.260 While
most of the concern is related to proficiency testing for RFLP meth-
ods, PCR is also included.
While there are problems associated with allowing the court
system to determine the quality of DNA testing, there is no need for
courts to stop admitting evidence obtained through properly con-
ducted and analyzed DNA test procedures. Concerns regarding the
courts' ability to determine the quality of DNA testing include the
fact that courts only see a fraction of a forensic scientist's analy-
ses.26 Also, if the charges are dropped against a suspect, the court
will never see the evidence, regardless of the analytical result. As
they do not have the expertise, resources or mechanisms to control
or supervise scientific quality control programs, courts should not
be expected to do so. Although the court is not the ideal forum for
ensuring quality science, the adversary process is a means by which
those who practice "bad" science may be discredited, while those
who practice "good" science may enjoy the credibility they deserve.
255. COMMITTEE ON DNA TECHNOLOGY IN FORENSIC SCIENCE, DNA TECHNOLOGY
IN FORENSIC SCIENCE (1992) [hereinafter DNA TECHNOLOGY].
256. FEDERAL BUREAU OF INVESTIGATION, U.S. DEPARTMENT OF JUSTICE, RE-
SPONSE TO THE REPORT BY THE COMMITTEE ON DNA TECHNOLOGY IN FORENSIC SCI-
ENCE (1992) [hereinafter FBI RESPONSE].
257. John W. Hicks, Message From the Assistant Director in Charge of the FBI Labora-
tory, 19 CRIME LABORATORY DIG. 41, 41 (1992).
258. Gina Kolata, U.S. Panel Seeking Restriction on Use of DNA in Courts, N.Y. TIMES,
Apr. 14, 1992, at AI, AI.
259. Id.
260. DNA TECHNOLOGY, supra note 255, at 97-110; Victor A. McKusick, Opening
Statement, April 14, 1992 (unpublished).
261. See Randolph N. Jonakait, Forensic Science: The Need for Regulation, 4 HARV. J.
L. TECH. 109, 166-172 (1991), for a discussion of the courts and the quality of forensic
science.
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Quality control/quality assurance262 is the responsibility of
those working in the laboratories. As with all professions, there are
no doubt individuals within forensics who do not act responsibly
nor even ethically. However, there are also many individuals within
the field who take professional pride in their work, act responsibly,
and treat their duty to the court with respect and honesty.
It is unfortunate that both the lay and legal literature on crime
labs has stressed the problems in such a way that it would appear
that every lab within the U.S. is inept and incompetent.263  This
may be at least partially fostered by the fact that while many
criminalists are scientists who work in the law enforcement setting,
some technicians working in crime labs have law enforcement back-
grounds, but no science education. 2 1 This is an area of concern, as
sometimes unqualified individuals attempt to undertake responsibil-
ity that is beyond their capabilities. However, just because a techni-
cian is involved in a case does not mean that their work is shoddy.
Technicians perform tasks according to strict protocols and their
work is overseen by a supervisor. They have no authority to make
procedural changes nor the latitude to exercise judgment. In con-
trast, the forensic scientist or analyst is foremost a scientist who
conducts the preliminary assessments of evidence as it is received,
identifies the legal and/or investigative questions which must be an-
swered in the case, and develops the analytical strategies to answer
those questions.26' The analyst either assigns the project to some-
one or conducts the analysis himself/herself, and then must inter-
pret the results. If there are any discrepancies or questions
regarding the test accuracy, the approach is to re-analyze the
evidence.
The ultimate results must then be explained in an impartial,
non-technical way to law enforcement personnel, attorneys, judges
262. Or, as it is now often termed, "continuous quality improvement."
263. Helvarg, supra note 254; George J. Annas, DNA Fingerprinting in the Twilight
Zone, HASTINGS CENTER REP., March/April 1990, at 35; Randolph N. Jonakait, supra note
261; Edward J. Imwinkelried, The Debate in the DNA Cases Over the Foundation for the
Admission of Scientific Evidence. The Importance of Human Error as a Cause of Forensic
Misanalysis, 69 WASH. U. L.Q. 19 (1991).
264. Helvarg, supra note 254, at 44.
265. George Sensabaugh, Genetic Typing of Biological Evidence, Comments for the
Cooper Amicus Brief, CAL. Assoc. CRIMINALISTS NEWSL., July 1987, at 11, 16.
As exemplified by the court in People v. Young, 381 N.W.2d 270 (Mich. 1986), some
courts and experts have a misguided belief that a higher degree (e.g., Ph.D.) is a prerequisite
for status as a scientist, or perhaps without a higher degree, one can't be anything more than
a technician. A scientist is a person who does science, regardless of the initials after their
name. The better assessment criteria are the responsibilities and expectations associated with
the person's position in employment and in the scientific community to which they belong.
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and juries. Thus, the forensic analyst bears a substantial burden of
responsibility for knowing what to do, how to do it and how to
explain it in terms understandable to the layperson. Regardless of
its importance, forensics training is often not readily available to
many experts.2 66 This is a great disservice to the legal system, as
the expertise of many scientists goes unappreciated and misunder-
stood by juries and judges.
B. Validation Studies, Standards and Proficiency Testing
As with any new technology, validation studies and proficiency
testing have been facets in the development of the AmpliType5
HLA DQca test kit. Concurrently, the growth of DNA analysis
stimulated much discussion and study into the regulation of labora-
tories conducting DNA testing. "Setting standards for forensic ap-
plications of DNA testing is the most controversial and unsettled
issue. Standards are necessary if high-quality DNA forensic analy-
sis is to be ensured, and the situation demands immediate atten-
tion. ' '2 67 In a recent' case, People v. Schwartz,2 68 the Minnesota
Supreme Court denied the admissibility of DNA test results on the
grounds that the lab performing the test did not meet TWGDAM
Guidelines or provide proper discovery. 269 TWGDAM is the FBI's
Technical Working Group on DNA Analysis Methods which is
charged with examining quality assurance, population statistics and
databanking. TWGDAM held its first meeting in November 1988,
and its members include representatives from crime labs which are
implementing or close to implementing DNA analysis, and com-
mercial laboratories. 270 It is somewhat ironic that at the time the
evidence was analyzed in Schwartz, there were no TWGDAM
guidelines available to follow.
Various professional organizations, such as the American Soci-
ety of Human Genetics, the California Association of Crime Labo-
ratory Directors (CACLD) and The Society for Forensic
Haemogenetics, have published official statements or position pa-
pers regarding DNA analysis.2 7 1 The interest in establishing a na-
266. Hollien, supra note 216, at 1416-1417.
267. GENETIC WITNESS, supra note 149, at 10.
268. 447 N.W.2d 422 (Minn. 1989).
269. Id. at 427-428.
270. GENETIC WITNESS, supra note 149, at 13; TWGDAM, Guidelines for a Quality
Assurance Program for DNA Restriction Fragment Length Polymorphism Analysis, 16 CRIME
LABORATORY DIG. 40 (1989).
271. Ad Hoc Committee on Individual Identification by DNA Analysis, The American
Society of Human Genetics, Individual Identification by DNA Analysis: Points to Consider, 46
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tionwide DNA database will help foster standardization and
conformity; consistency is required if an efficient and useful com-
puterized system is to be established. 27 2 Setting the necessary stan-
dards will require much thought and research.
As must be done with all new test systems, extensive validation
studies have already been conducted on PCR. These studies have
shown that DQa typing can be accomplished without producing
false positive or false negative results.
273
C. AmpliTypec Kit Development
Validation and proficiency testing have been important aspects
of the AmpliTypef kit since its inception. In 1986, the FBI ap-
proached Cetus about PCR-based forensic DNA typing. In 1989, a
prototype DQa typing system was sent to the FBI and beta testing
of the Cetus AmpliTypetlD kit began. From 1989-1990, over 3,000
samples were analyzed by the FBI, including fresh samples, dried
stains, and samples for population studies. Research on the effects
of sample exposure to light, chemical and biological agents was also
performed. The AmpliType( kit did not become available for sale
in the U.S. until February, 1990. In March, 1990, it became avail-
able in Europe, Australia and Asia. From late 1990 to May 1991,
the FBI analyzed over 750 casework samples.2 7 4
There are also other mechanisms for proficiency testing in
place. 275 For example, CACLD conducted two rounds of blind
AM. J. HUM. GENETICS 631 (1990); California Association of Crime Laboratory Directors,
Position on DNA Typing of Forensic Samples, CAL. Assoc. CRIMINALISTS NEWSL., April
1988, at 4; AABB Parentage Committee: Proposed Standards for Tests Involving DNA
Polymorphisms-November 1987, reprinted in CAL. Assoc. CRIMINALISTS NEWSL., April
1988, at 5; Statement of the Society for Forensic Haemogenetics Concerning DNA Polymorph-
isms, reprinted in CAL. AsSOC. CRIMINALISTS NEWSL., April 1988, at 5. On Mar. 30, 1990,
a resolution was adopted by the CACLD membership to endorse the TWGDAM guidelines
for DNA analysis and support establishment of a national forensic data base system based on
the FBI's RFLP analysis.
272. Stanley D. Rose & Tim P. Keith, Standardization of Systems: Essential or Desira-
ble?, BANBURY REP 32: DNA TECH AND FORENSIC SCi. 319, 319 (1989); and Henry C. Lee
& Robert E. Gaensslen, The Need for Standardization of DNA Analysis Methods, BANBURY
REP 32: DNA TECH AND FORENSIC SCL. 217 (1989).
273. Catherine T. Comey et al., Validation Studies on the Analysis of the HLA DQa
Locus Using the Polymerase Chain Reaction, 36 J. FORENSIC SCI. 1633 (1991).
274. Sharon Reid, U.S. and International Use of the AmpliTyped Kit, presented at a
PCR Workshop Presented by Cetus for the California Association of Criminalists (May 18,
1991).
275. Proficiency testing is currently offered through programs such as the Collaborative
Testing Service (CTS), in association with the Forensic Science Foundation (FSF). Participa-
tion in this program is voluntary and anonymous. It includes physiological fluids and sam-
ples for DNA testing. GENETIC WITNESS, supra note 149, at 79-80.
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proficiency tests with Cellmark, Lifecodes and Forensic Science As-
sociates/Cetus (FSA/Cetus).
D. California Association of Crime Laboratory Directors
(CA CLD) Tests
In the first round of 51 samples, Lifecodes obtained DNA re-
sults from 37 samples and made no errors. In its set of 50 samples,
Cellmark obtained DNA results from 44 samples and made 1 incor-
rect match. This was a human error which was subsequently reme-
died by purchasing a large capacity centrifuge, thereby reducing
sample manipulation. FSA/Cetus obtained results for all 50 of the
samples provided. There was one incorrect match reported. Again,
this was due to a human error (failure to introduce a sample into
the appropriate chamber or a bubble in the vacuum apparatus),
which was subsequently remedied by the routine testing of all sam-
ples in duplicate.2" 6
In the second round of testing, all three laboratories received
50 samples. Lifecodes obtained results for 48 samples, while FSA/
Cetus obtained results for all 50 samples. Neither Lifecodes nor
FSA/Cetus reported any incorrect matches. Cellmark obtained re-
sults for 45 samples, reported that two samples gave inconclusive
results and made one incorrect match.277
The errors made in the blind trials were all human errors, not
errors that decreased the reliability of the procedure itself. In deter-
mining the admissibility of a technology, it is important to distin-
guish between the validity of the technology and the possibility that
human error may lead to an incorrect result in the application of
that technology. The statistical probabilities obtained with DNA
testing (e.g., RFLP) have nothing to do with the possibility of
human error in the performance of the test. While the possibility of
human error is unfortunate, it can never be totally eliminated. 278
Apparently, unlike most people (including attorneys, who may
also be involved in a case involving life and death), criminalists are
subject to a requirement of 100% accuracy. Not only is this unfair
to the scientists who are conducting the work, it is impossible.
While some commentators decry the errors made in the crime lab as
276. If significantly different results are observed for these duplicate tests, the scientist is
on notice that there is a problem and the test should be repeated.
277. Report of CACLD Blind Trial #2, March 29, 1990.
278. Frederick R. Millar, Jr., DNA: Facts and Myths, CAL. L., July 1989 at 12 (letter to
the editor).
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unacceptable,279 it is important for those within the legal profession
to recognize that crime labs are not infallible. As with all profes-
sionals, including attorneys, forensic scientists should be held to a
reasonable standard of care.
The technology is ready and able to do what it was designed to
do; the potential for human error(s) must be recognized and fail-
safe protocols must be followed in order to avoid erroneous results.
Testing samples in duplicate, saving aliquots of samples for later
testing, careful labelling of samples and meticulous record-keeping
all help reduce the potential for human error. Thus, there are meth-
ods by which forensic scientists may reduce the possiblity of such
error. These factors should be taken into consideration when the
court addresses the weight, not the admissibility of the evidence.
Critics of proficiency programs argue that the results serve to
emphasize the need for tighter control, including mandatory regula-
tion through legislation. 280 In a rather contentious debate, played
out in the editorial section of "California Lawyer," it was claimed
that in a recent hearing in Ventura, "the president of the California
Laboratory Directors and two other association members covered
up errors made by a commercial DNA laboratory in a "blind" test
of its accuracy."'28 ' Another author, Mark Thompson also stated,
[F]or that matter, it turns out the proficiency test wasn't exactly
blind. One of the genetic fingerprinting labs, Cellmark Diagnos-
tics, initially turned in its result in a form that was "unintel-
ligible," admitted Margaret Quo head of the Orange County
Sheriff's Department crime lab, in recent testimony in a Ventura
County hearing. She contacted Cellmark officials, met with them
to review the problems, and allowed them to submit cleaned up
conclusions three months later. That laundered report is what
was released as the results of a "blind" proficiency test.282
In a response letter, CACLD DNA Committee members Jan
Bashinski, Linda Hartstrom and Margaret Kuo (not "Quo") stated:
[T]he CACLD DNA Committee conducted the blind trials fairly
and honestly. Neither the organization nor the individual com-
mittee members and the agencies they represent benefit finan-
cially or personally from administering the test irrespective of the
outcome. To suggest that we would jeopardize our reputation to
help cover up Cellmark's error is ridiculous. 283
279. Jonakait, supra note 261.
280. GENETIC WITNESS, supra note 149, at 149.
281. William C. Thompson, Letter to the Editor, CAL. L., July 1989, at 16.
282. Mark Thompson, Letter to the Editor, CAL. L., July 1989, at 16.
283. Jan Bashinski et al., More on DNA, CAL. L., Sept. 1989, at 17.
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Mr. William Thompson's statement that there was a cover up
regarding the CACLD DNA proficiency study is completely false.
The hearing he refers to was in People v. Axell,2s4 at which, on May
8, 1989, Margaret Kuo testified regarding the CACLD study.
In a responsive "Letter to the Editor," Carol J. Nelson, the
prosecutor in People v. Axell,285 stated that claims made in Dr.
Thompson's letter were "patently untrue." She suggests reading
the transcripts of the Kelly-Frye hearing to determine the amount of
weight Ms. Kuo's and Mr. Thompson's testimony on both direct
and cross-examination should be given. For example, "he is cur-
rently earning a significant percentage of his income attacking
DNA identification in courts throughout the country. As such, he
is hardly an unbiased observer of what is happening in the court-
room or in the field of DNA identification.1 286
This whole sequence of letter exchanges has another layer of
involvement. The letter from Mr. William Thompson was printed
despite an appeal to the editor by the author to remove the inaccu-
rate reference to a cover-up. Also, the editor was initially unwilling
to publish Ms. Nelson's response letter. This led the CACLD DNA
Committee to consult an attorney and send a response letter. The
editor printed a portion of the letter, not including a reference to the
request Dr. Thompson made to alter his original letter to the editor.
Thus, in addition to the expert witnesses who travel around the
country and testify against DNA testing admissibility in court, the
legal press is also distorting the facts regarding cases and testimony.
As of mid-February 1990, DNA typing evidence has prevailed in
virtually every legal skirmish. In spite of this overwhelming suc-
cess, media portrayals, such as a January New York Times arti-
cle, "Some Scientists Doubt the Value of Genetic Fingerprint
Evidence," continue in their attempts to polarize and sensation-
alize the issues, often taking quotations out of context. If DNA's
legal successes were covered as thoroughly as its few setbacks,
the readership would be bored to tears .... Opponents of the
technology point to their few limited successes, ignoring the real-
ity of the entire legal experience to date.28 7
For the benefit of all who have read the various opinions, the
facts were that the blind aspect of the testing was never compro-
mised, there never was a "cover-up," nor has Margaret Kuo given
284. Ventura Sup. Ct. CR-2391 1, May, 1989.
285. Carol J. Nelson, Letter to the Editor, CAL. L., Sept. 1989, at 17-18.
286. Id.
287. Rockne Harmon, supra note 245, at 6.
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any testimony to support this claim.
2 8
E. Federal Legislation
There have been two bills introduced into Congress which deal
with DNA testing. The first bill, H.R. 3371, known as the "DNA
Identification Act of 1991" (Edwards bill) was introduced by Rep-
resentative Don Edwards in 1991 and incorporated into the 1991
Crime Control Act passed by the House of Representatives. 2 9 This
bill was drafted in consultation with the FBI and the forensic com-
munity; the FBI has registered its support of the bill.2 90 The bill
would authorize a DNA advisory board with the responsibility of
recommending standards for quality assurance and proficiency test-
ing to the FBI Director, who after consideration, would issue stan-
dards to serve as the basis for proficiency testing programs
administered by laboratory testing organizations.29 '
The other bill, H.R. 339, known as the "DNA Proficiency
Testing Act of 1991" (Horton Bill), was introduced by Representa-
tive Frank Horton in January, 1991. This bill requires that states
desiring to acquire equipment through federal funds, agree that
their labs will meet standard guidelines and participate in profi-
ciency testing at least every six months.2 92 This bill proposes that
the FBI publish DNA testing standards based on TWGDAM
guidelines and that the FBI certify forensic DNA laboratory profi-
ciency testing programs. The bill also provides that the DNA
database program under development by the FBI in conjunction
with state and local forensic laboratories be tied to the requirements
of the Act. 293 The FBI does not support the Horton Bill and op-
poses a direct regulatory role for itself.294 Thus, it remains to be
determined who will regulate forensic labs who conduct DNA tests.
288. For accounts of the blind trials, see Statement of the DNA Committee Regarding the
Cellmark Blind Trial Report, DNA COMMITTEE REPORT (1989).
289. DNA Identification Act of 1991 (H.R. 3371) Title X, Omnibus Crime Control Act
of 1991, §§ 1002, 1003, 1004.
290. The FBI's Responses to Recommendations by the NRC'S Committee on DNA Tech-
nology in Forensic Science, 19 CRIME LABORATORY DIG. 55-56 (1992) (hereinafter The FBI's
Response].
291. Id.
292. H.R. 339 (1991).
293. This program, designated CODIS (Combined DNA Index System) is the FBI's na-
tional DNA identification system which is being designed to allow the storage and exchange
of DNA records submitted by state and local forensic DNA laboratories. FEDERAL BUREAU
OF INVESTIGATION, U.S. DEPARTMENT OF JUSTICE, LEGISLATIVE GUIDELINES FOR DNA
DATABASES (1991).
294. The FBI's Response, supra note 290, at 56.
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If not the U.S. Department of Health Services, it is likely that the
responsibility will fall on the states.
F. State Regulation
In addition to the federal government, states have the authority
to regulate forensic DNA typing by both private labs and public
crime laboratories. At first blush, it would appear that the State
Department of Health Services (Health Services) would be the ap-
propriate regulatory branch to oversee forensic DNA labs, as this
department is responsible for clinical and public health labs.29
However, regardless of the source of the regulations, it is important
to remember that regulation in itself will not solve all of the
problems.
For example, the experience in California crime labs in the
context of blood alcohol regulation is very disturbing. The Depart-
ment of Health Services oversees blood alcohol testing in the state
and has set forth very exacting requirements for labs conducting
these tests.29 6 There are some very real problems in the relationship
between the state's labs and Health Services, which could make effi-
cient regulation of DNA labs very troublesome. 297
In order to avoid the regulatory problems caused by Health
Services, the CACLD Professional Practices Committee prepared a
legislative proposal in 1989 which would have organized a Board of
Forensic Science Practices administered under the auspices of the
Department of Consumer Affairs.29 The Board of Forensic Sci-
ence Practice was not accepted by the Attorney General's Advisory
Board; the Attorney General declined to sponsor legislation to cre-
ate the bodies recommended by CACLD, and the Governor
dropped funding for all of the proposed regional DNA labs with the
exception of the Department of Justice lab in Berkeley. Thus, state
regulation, at least in California, is on questionable footing.
295. With the implementation of CLIA see supra note 251, public health and other de-
partments may not have the personnel nor funds to initiate involved regulatory programs for
forensic laboratories.
296. For example, there are a number of pages of complex regulations governing
breathalyzer tests within the CAL. REGS., tit. 17, §§ 1215-1222.2.
297. For example, while there is a mechanism for input to the Health Services Director
concerning regulations regarding forensic alcohol analysis provided for in CAL. HEALTH &
SAFETY CODE § 436.50 (West 1990)(amended 1992), and an "Advisory Committee" was
formed, this committee has not met since 1985. Also, although procedural changes must be
submitted to Health Services, it may take three years to gain approval. Telephone Interview
with Kathryn Holmes, Contra Costa Crime Laboratory (Jan. 10, 1992).
298. PROFESSIONAL PRACTICES COMMITTEE OF THE CALIFORNIA ASSOCIATION OF
CRIME LABORATORY DIRECTORS, REPORT TO THE BOARD (1989).
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G. Self-Regulation
Self-regulation is another avenue by which the goals of regula-
tion may be achieved without the intervention of a regulatory
agency.2 99 The California Association of Criminalists has instituted
a voluntary written examination for Certificates of Professional
Competency in Criminalistics. The test and certification program
recognize the variety inherent in criminalistics and are designed to
demonstrate that the criminalist has a basic understanding of the
underlying concepts, principles and other aspects of the profes-
sion.3" While it is a completely voluntary program, it does repre-
sent a step toward responsible self-regulation of the criminalistics
profession at the local level.
Because of the diverse subject areas within forensics, a uni-
form, federal regulatory or proficiency testing program for all of
these areas would require a large commitment of manpower,
money, effort and time. For example, criminalists may be required
to gain expertise in such diverse areas as protein, organic and inor-
ganic chemistry, molecular biology, biology, firearms, arson, explo-
sives, fingerprint comparisons, photography, computers and other
electronic equipment, analysis of drugs, soil, fiber, glass, animal and
human hair, human and animal sperm, bloodstains, blood spatters,
paint, gunshot residue, alcohol, inks and handwriting, questioned
documents, and various other disciplines.
Again, the major considerations are economic. Who will pay
for all of this? Is the public willing to foot the bill for a system that
in most instances already works quite well? There is a fair
probability that the cost of regulating all of the subdisciplines
within crime labs would be too exorbitant, especially considering all
299. GENETIC WITNESS, supra note 149, at 73-75. Self-regulation is also described in
Jan S. Bashinski, Laboratory Standards: Accreditation, Training and Certification of Staff in
the Forensic Context, BANBURY REPORT 32: DNA TECHNOLOGY AND FORENSIC SCI. 159
(1989). The American Society of Crime Laboratory Directors (ASCLD) is another profes-
sional forensic science organization which has established voluntary quality assurance pro-
grams through a nationwide crime lab accreditation program.
300. An Open Letter to the Association Membership, CAL. Assoc. CRIMINALISTS
NEWSL., Jan. 1990, at 10.
The American Board of Criminalistics (ABC) will administer the first ABC General
Examination in 1993. ABC Diplomate certificates will be available for those who received
the California Association of Criminalists Certificate of Professional Competency in
Criminalistics. The ABC certificates will expire five years after their dates of issuance. For
Diplomate status, applicants must possess a minimum of an earned baccalaureate degree or
its equivalent in a natural science or an appropriately related field from an accredited institu-
tion. A minimum of two years full-time experience of active work in criminalistics is also
required. "Fellow" status has additional experience and testing requirements. American
Board of Criminalistics, Inc., Certification Process, Sept. 1992.
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of the effort that would be expended to oversee such a compara-
tively small number of laboratories. The cost-benefit ratio would
likely tilt toward non-regulation.
Regardless, the self-regulation route would require much coop-
eration between crime labs and law enforcement agencies nation-
wide, if a nationwide DNA database program is to be effective. In
some aspects, it also comes back to the legal profession. While the
prosecution often has no choice in the laboratory facility used, the
defense may utilize any laboratory it wishes. If an attorney uses a
laboratory with a questionable reputation, the work product will
also seem questionable. It is very prudent to know the strengths
and weaknesses of each lab available; the networks within the legal
community should make this type of information readily available.
With the importance of the issues involved in criminal trials, the
choice of crime laboratory (and, perhaps, analytical method) would
seem to warrant at least the same amount of consideration as one
puts into choosing a family physician.
H. Who Will Be Regulated, and By Whom
Regardless of the method, proficiency testing of DNA analysis
methods is on its way. It remains to be seen how standards will be
implemented. Another unknown is the identity of the agency re-
sponsible for implementing these standards. For example, will fed-
eral and/or state regulatory agencies (such as Health Services) have
roles to play? Hopefully, the regulations will be fair, meaningful,
reasonable and practical.
While it appears likely that forensics regulations will be mod-
elled after those for clinical laboratories, the rule-makers must re-
member that crime labs and clinical labs are very different entities.
While they will be able to draw from the experience gained from
clinical laboratory regulation in order to keep from reinventing the
wheel, crime labs serve very different functions and clientele. Un-
like clinical laboratories, crime labs do not have patients who pay
for their services. Thus, crime labs cannot pass costs along to con-
sumers. It is highly unlikely that defendants will be made to pay for
the evidentiary analyses associated with the alleged crime. Also,
who will be regulated-all crime labs, only those associated with
police departments, only private labs, etc.? Thus, while regulation
and proficiency testing requirements are inevitable, many questions
remain, such as:
(1) Who will pay for the proficiency testing?
(2) Who will prepare and distribute the necessary samples?
2003]
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(3) Will it be mandatory or voluntary?
(4) Will it apply to all laboratories or just those associated with
law enforcement agencies (i.e., prosecution)? 30 1
(5) What role will state agencies, such as Health Services play?
(6) Will professional societies and organizations have a voice in
regulation implementation?
(7) Will regulation extend to other areas of criminalists (e.g.,
questioned documents, firearms, drug analysis, microscopy, fin-
gerprinting etc.)? and
(8) Will certification of criminalistics be required and if so, how
will this be administered?
CONCLUSIONS AND PROGNOSTICATIONS FOR THE FUTURE
While RFLP will undoubtedly continue to be an important test
method in DNA analysis both within and beyond the forensic com-
munity, it is almost inevitable that PCR will supplant it. The ease
of use, the very minimal requirement of a single nucleated cell, and
the elegant simplicity of the entire methodology make it particu-
larly attractive for use in the crime lab setting. Although contami-
nation is a potential problem, care in laboratory design and
protocols will help ensure that it will not be a factor in genetic anal-
yses of forensic samples. It is quite possible that combination sys-
tems like the "AmpFLP's" now available or direct sequencing in
combination with PCR will supplant both PCR alone and RFLP.3 °2
The development of alternative test systems, including the mi-
tochondrial30 3 DNA test procedures used to identify "missing" per-
301. For example, in California, the prosecution must use an accredited laboratory for
its alcohol analyses, while the defense can go anywhere, no matter how incompetent the lab
is.
302. See supra notes 118-119 for various references other advances have also proven to
be significant improvements in PCR analysis. A modified DNA extraction process using
Chelex® 100 has been developed, which appears to provide better results and facilitates the
combination of PCR and RFLP. Sean Walsh et al., Chelex 100 as a Medium for Simple
Extraction of DNA for PCR-Based Typing From Forensic Material, 10 BIOTECHNIQUES 506
(1991). Chelex® 100, followed by PCR of DQca and DIS80 were recently used to genetically
characterize saliva from cigarette butts. This study included three cigarette butts recovered
from two crime scenes (adjudicated cases) and indicated that PCR-based DNA typing is a
potential method for analyzing traces of saliva left on such seemingly innocuous pieces of
evidence as cigarette butts. Hochmeister, supra note 195.
303. Mitochondria are "organelles" contained within cells which serve as the cell's en-
ergy factory. Any energy the cell needs to survive or divide is obtained through the inten-
sively biochemically active mitochondria. ALBERTS ET AL., supra note 9, at 484-500.
Unlike the other organelles within the cell's cytoplasm (with the exception of the nu-
cleus, the cytoplasm comprises the entire area within the cell), mitochondria contain their
own complement of DNA. It is hypothesized that mitochondria represent the evolutionary
"remains" of bacteria which infected cells long ago and were commandeered by the cells as
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sons in Argentina, 3" also have additional potential for the forensic
setting and parentage determinations.3"' As mitochondrial DNA is
inherited only through the maternal lineage, the maternal history of
a person may be determined by analyzing their mitochondrial
DNA.30 6 This is also of great potential value in the study of genetic
diseases, especially those which have a sex-linked component.
Modified PCR methods designed to analyze RNA have proven
to be extremely valuable, especially in the development of medical
diagnostic tests. It is also possible that RNA analysis could be uti-
lized in the forensic setting.
The future of DNA analysis as applied to forensics as well as
the traditional areas of medical research appears quite bright. Per-
haps the best advice to the legal community is to be prepared.30 7
Before deciding whether or not to use DNA analysis in court, the
attorney will need to obtain many items and much information
from the laboratory doing the analysis, and should if at all possible,
visit the site in order to get a first-hand feel for the facility and the
people doing the work.3"8
As additional techniques and refinements are developed, it is
likely that the technology will continue to improve as well. As ad-
ditional PCR systems are developed, they must be thoroughly char-
acterized and proven to be reliable. During the time the kits are
developed and marketed, it would be to the profession's ultimate
benefit if they were subjected to the same rigorous standards as are
applied to clinical diagnostic test kits. Although this would delay
energy factories. This is supported by the fact that mitochondria contain DNA which is
completely independent of the DNA contained within the nucleus. Id. at 541-542.
304. Chris Raymond, Forensics Experts Tackle Task of Identifying Thousands of "Disap-
peared' Victims, 261 JAMA 1388 (1989).
305. Denise S. Rath & Carl R. Merril, Mitochondrial DNA and Its Forensic Potential,
PROC. INT'L SYMP. FORENsIc AsPEcTs DNA ANALYSIS 113 (1989).
306. Allan C. Wilson & Rebecca L. Cann, The Recent African Genesis of Humans, Sci.
AM., April, 1992, at 68; and R. Cann et al., Polymorphic Sites and the Mechanisms of Evolu-
tion in Human Mitochondrial DNA, 106 GENETIcS 479 (1984).
307. As legend has it, Pasteur once said, "Chance favors the prepared mind."
308. The decision whether or not to use DNA will require much thought. Be sure to get
a copy of the complete lab file for the case, a list of the standard operating procedures (espe-
cially those used in your case), a curriculum vitae of the person who performed the test (it
might be advisable to also get a copy of their supervisor's curriculum vitae as well), peer-
reviewed articles characterizing the probes used in your case, if RFLP was done, a descrip-
tion of the database used in your case (including allele frequencies, sample sources, database
size and any ethnic characterizations of the samples) and a description of the method to
calculate frequencies and the confidence intervals applicable to the case. Be sure to also get
copies of the curriculum vitae for all the expert witnesses you might use. Finally, be sure to
determine if there are any relationships between the testing laboratory and the expert
witnesses.
162 SANTA CL.ARA COMPUTER & HIGH TECH. 1... [Vol. 20
354 COMPUTER & HIGH TECHNOLOGY L4W JOURN4L [Vol. 9
the introduction of new methods and/or genetic markers, it would
help decrease the amount of court time and written criticism dedi-
cated to the use of genetic markers in the legal system. However,
regardless of its future development, a firm foundation of reliability
and tremendous usefulness is in place.
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